UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

x	~~QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934~~

For the quarterly period ended December ~~30, 2012~~

31, 2013

[ ] o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ~~_____~~ to ~~_____~~

Commission file number ~~1-8402~~001-08402

ISC8 INC.

(Exact Name of Registrant as Specified in Its Charter)


Delaware		33-0280334
(State or Other Jurisdiction of Incorporation or Organization)		(I.R.S. Employer Identification No.)

~~3001 Red Hill Avenue,~~151 Kalmus Dr., Suite A-203

Costa Mesa, California 92626

(Address of Principal Executive Offices) (Zip Code)

~~(714) 549-8211~~

(Registrant’s Telephone Number, Including Area ~~Code)~~Code:

(714) 444-8753

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended ~~(the “~~(“Exchange Act”) during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See ~~the definitions~~definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer		[ ]		Accelerated filer		[ ]
Non-accelerated filer		[ ]		Smaller reporting company		[X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [X]

As of February ~~11, 2013,~~12, 2014, there were ~~147,992,000~~231,681,476 shares of common stock outstanding.

~~Table of Contents~~ISC8 INC.

~~ISC8 INC.~~

QUARTERLY REPORT ON FORM 10-Q

FOR THE FISCAL PERIOD ENDED DECEMBER ~~30, 2012~~31, 2013

TABLE OF CONTENTS

		PAGE

		~~PAGE~~
PART I – FINANCIAL INFORMATION

Item 1.	Financial Statements		1

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		16
				20
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	25
Item 4.	Controls and Procedures	26
		25
	PART II – OTHER INFORMATION

Item ~~4. Controls and Procedures~~1.		25

~~PART II OTHER INFORMATION~~

~~Item 1.~~ Legal Proceedings		26
				27
Item 1A.	Risk Factors		26
				27
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		26
				27
Item 6.	Exhibits		27		28

Signatures		28

Unless otherwise indicated, or unless the context of the discussion requires otherwise, we use the terms “ISC8,” “Irvine Sensors,” the “Company,” “we,” “us,” “our” and similar references to refer to ISC8 Inc. and its subsidiaries. ISC8®, ISC8[secure] ®, Irvine Sensors®, Cyber adAPT™, NetFalcon™, NetControl™, Neo-Chip™, Neo-Stack®, Neo-Layer™, TOWHAWK®, Novalog™, Vault®, Eagle™, and RedHawk™ are among the Company’s trademarks. Any other trademarks or trade names mentioned in this report are the property of their respective owners.

Safe Harbor Regarding Forward Looking Statements

~~The Private Securities Litigation Reform Act of 1995 and other securities laws contain certain safe harbors regarding forward-looking statements.~~ From time to time, information provided by us or statements made by our employees may contain “forward-looking” information which involves risks and uncertainties. Any statements in this Quarterly Report and accompanying materials that are not statements of historical fact are forward-looking statements (including, but not limited to, statements concerning our projected revenues, expenses, gross profit and income, mix of revenue, demand for our products, the need for additional capital, our ability to ~~obtain and successfully perform additional new contract awards and the related funding of such awards, our ability to~~ repay our outstanding debt, market acceptance of our products and technologies, the competitive nature of our business and markets, the success and timing of new product introductions and commercialization of our technologies, product qualification requirements of our customers, the need to divest assets, our significant accounting policies and ~~estimates, and the outcome of expense audits)~~estimates). These forward-looking statements are based on a number of assumptions made by us, and involve a number of risks and uncertainties, and accordingly, actual results could differ materially. Factors that may cause such differences include, but are not limited to, those discussed in this Quarterly Report and set forth in Part I, Item 1A of our Form 10-K for the year ended September 30, ~~2012, as updated in our Quarterly Report on Form 10-Q for the quarter ended January 1, 2012,~~2013 available through the website of the Securities and Exchange Commission (“SEC”) at www.sec.gov, our website at www.isc8.com, or upon written request to our Investor Relations Department at ~~3001 Red Hill Avenue,~~151 Kalmus Drive, Suite A-203, Costa Mesa, California 92626. You should carefully consider these factors in connection with forward-looking statements concerning us.

Except as required by law, we undertake no obligation to update these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

-i-

~~Table of Contents~~

PART I

~~FINANCIAL~~ ~~INFORMATION~~

FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

ISC8 INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited)

	December 30, 2012			September 30, 2012
	(Unaudited)						December 31, 2013			September 30, 2013 (1)
Assets
Current assets:
Cash and cash equivalents	$	427,000		$	1,738,000		$	375,000		$	136,000
Accounts receivable, net		407,000			445,000			-			119,000
Due from Vectronix, Inc.		1,200,000			1,200,000
Unbilled revenues on uncompleted contracts		642,000			549,000
Deposit on PFG credit line								500,000			1,000,000
Prepaid expenses and other current assets		331,000			113,000			574,000			561,000
Total current assets		3,007,000			4,045,000			1,449,000			1,816,000
Restricted cash								75,000			75,000
Property and equipment, net		859,000			952,000			693,000			753,000
Goodwill								393,000			393,000
Intangible assets, net		882,000			9,000			758,000			790,000
Deferred financing costs		852,000			963,000
Goodwill		393,000			-
Deposits		173,000			172,000
Deferred financing costs, net								64,000			715,000
Other assets								89,000			126,000
Non-current assets of discontinued operations								293,000			297,000
Total assets	$	6,166,000		$	6,141,000		$	3,814,000		$	4,965,000

Liabilities and Stockholders’ Deficit
Current liabilities:
Accounts payable	$	952,000		$	815,000		$	823,000		$	1,024,000
Accrued expenses		2,653,000			2,514,000			1,538,000			3,066,000
Advance billings on uncompleted contracts		278,000			297,000
Deferred revenue		197,000			-			134,000			221,000
Senior secured revolving credit facility loan, net of discounts		4,647,000			4,567,000
Senior secured revolving credit facility, net of discount								3,073,000			4,908,000
Senior subordinated secured convertible promissory notes, net of discount		5,312,000			1,119,000			1,610,000			15,793,000
Senior subordinated secured promissory notes		4,934,000			4,790,000			-			5,392,000
Other current liabilities		31,000			34,000
Capital lease obligations, current portion								415,000			447,000
Current liabilities from discontinued operations								625,000			678,000
Total current liabilities		19,004,000			14,136,000			8,218,000			31,529,000
Subordinated secured convertible promissory notes, net of discounts		6,752,000			6,470,000
Subordinated secured convertible promissory notes, net of discount								782,000			8,570,000
Capital lease obligations, less current portion								86,000			77,000
Derivative liability		15,625,000			19,925,000			124,000			19,245,000
Executive Salary Continuation Plan liability		974,000			975,000
Executive salary continuation plan liability								942,000			957,000
Other liabilities		59,000			65,000			75,000			139,000
Total liabilities		42,414,000			41,571,000			10,227,000			60,517,000
Commitments and contingencies (Note 8)
Commitments and contingencies (Note 11)
Stockholders’ deficit:
Convertible preferred stock, $0.01 par value, 1,000,000 shares authorized, Series B – 900 shares issued and outstanding (1); liquidation preference of $926,000		-			-
Common stock, $0.01 par value, 800,000,000 shares authorized, 142,352,000 and 131,559,000 shares issued and outstanding as of December 30, 2012 and September 30, 2012, respectively(2)		1,424,000			1,316,000
Common stock held by Rabbi Trust		(1,021,000	)		(1,021,000	)
Deferred compensation liability		1,021,000			1,021,000
Convertible preferred stock, $0.01 par value, 1,000,000 shares authorized, 900 shares of Series B Convertible Cumulative Preferred Stock issued and outstanding as of December 31, 2013 and September 30, 2013, liquidation preference of $866,000, and 2,757 and 0 shares of Series D Convertible Preferred Stock issued and outstanding, liquidation preference of $27,570,000 and $0, as of December 31, 2013 and September 30, 2013, respectively(2)								-			-
Common stock, $0.01 par value, 2,000,000,000 and 800,000,000 shares authorized; 231,681,000 and 205,581,000 shares issued and outstanding at December 31, 2013 and September 30, 2013, respectively (3)								2,317,000			2,056,000
Paid-in capital		175,397,000			174,157,000			230,688,000			181,443,000
Accumulated other comprehensive income		(2,000	)		-
Accumulated other comprehensive loss								23,000			(123,000	)
Accumulated deficit		(213,391,000	)		(211,227,000	)		(239,765,000	)		(239,252,000	)
ISC8 stockholders’ deficit		(36,572,000	)		(35,754,000			(6,737,000	)		(55,876,000	)
Non-controlling interest		324,000			324,000
Noncontrolling interest								324,000			324,000
Total stockholders’ deficit		(36,248,000	)		(35,430,000	)		(6,413,000	)		(55,552,000	)
Total liabilities and stockholders’ deficit	$	6,166,000		$	6,141,000		$	3,814,000		$	4,965,000

~~(1)~~	~~The number of preferred stock issued and outstanding are rounded to the nearest hundred (100).~~
~~(2)~~	~~The number of shares of common stock issued and outstanding are rounded to the nearest one thousand (1000).~~

(1) The condensed consolidated balance sheet as of September 30, 2013 was derived from the audited consolidated financial statement included in the Company’s 2013 Annual Report on Form 10-K, filed with the SEC on December 24, 2013 adjusted to reflect discontinued operations. In March 2013, the Company ceased operations of its government focused business, including Secure Memory Systems, Cognitive Systems and Microsystems business units (the “Government Business”). In accordance with the provisions of the Presentation of Financial Statements Topic 205 of the Accounting Standards Codification (“ASC”), the assets and liabilities related to the Government Business are now presented as discontinued operations for all periods presented in the consolidated financial statements.

(2) The number of shares of Convertible Preferred Stock issued and outstanding has been rounded to the nearest one hundred (100).

(3) The number of shares of Common Stock issued and outstanding has been rounded to the nearest one thousand (1000).

See Accompanying Notes to Condensed Consolidated Financial ~~Statements.~~

Statements

-1-

Table of Contents

ISC8 INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

~~(Unaudited)~~(unaudited)

	Quarter Ended
	December 31, 2013			December 31, 2012(1) (2)

Revenues	$	93,000		$	93,000
Cost of revenues		48,000			48,000
Gross Profit		45,000			45,000
Operating expenses:
General and administrative expense		2,375,000			2,368,000
Research and development expense		1,898,000			1,968,000
Total operating expenses		4,273,000			4,336,000
Operating loss		(4,228,000	)		(4,291,000	)
Interest and other (income) expense
Interest expense		3,928,000			1,987,000
Gain from change in fair value of derivative liability		(7,334,000	)		(4,947,000	)
Gain on extinguishment of debt		(316,000	)		-
Other (income) expense		4,000			(1,000	)
Total interest and other (income) expenses		(3,718,000	)		(2,961,000	)
Loss from continuing operations before provision for income taxes		(510,000	)		(1,330,000	)
Provision for income taxes		3,000			-
Loss from continuing operations		(513,000	)		(1,330,000	)
Loss from discontinued operations (net of $0 tax)		-			(834,000	)
Net loss	$	(513,000	)	$	(2,164,000	)

Basic and diluted net loss per common share
Loss from continuing operations	$	-		$	(0.01	)
Loss from discontinued operations	$	-		$	(0.01	)
Net loss per share, basic and diluted	$	-		$	(0.02	)

Basic and diluted weighted average number of common shares outstanding		224,816,000			141,394,000

   13 Weeks Ended

December 30,
2012

January 1,
2012

Total revenues    $ 875,000    $ 1,297,000

Cost and expenses
Cost of revenues    629,000    961,000
General and administrative expense    2,927,000    2,551,000
Research and development expense    2,444,000    1,831,000

Total costs and expenses    6,000,000    5,343,000

Loss from operations    (5,125,000 ) (4,046,000)
Interest expense    (1,987,000 ) (1,669,000)
Change in fair value of derivative liability    4,947,000    (2,310,000 )
Other income    1,000    1,000

Loss from continuing operations before provision for income taxes    (2,164,000)    (8,024,000)
Provision for income taxes    -    (3,000)
Loss from continuing operations    (2,164,000)    (8,027,000)

Loss from discontinued operations    -    (223,000)

Net loss    $ (2,164,000)    $ (8,250,000)

Basic and diluted loss per share
Loss from continuing operations    $ (0.02)    $ (0.07 )

Loss from discontinued operations    (0.00)    (0.00 )

Net loss per share, basic and diluted    $ (0.02)    $ (0.07 )

Weighted average number of common shares outstanding, basic and diluted    141,394,000    113,716,000

(1) In March 2013, the Company ceased operations of its government focused business, including Secure Memory Systems, Cognitive Systems and Microsystems business units (the “Government Business”). In accordance with the provisions of the Presentation of Financial Statements Topic 205 of the Accounting Standards Codification (“ASC”), the results of operations related to the Government Business are now presented as discontinued operations for all periods presented in the consolidated financial statements.

(2) On June 28, 2013, the Company changed its fiscal year end-date from the last Sunday of September to September 30. Accordingly, the first fiscal quarter of 2012 was previously reported as December 30, 2012. We did not change the prior period presentation to reflect the change in fiscal year as the difference is not material. See Note 1 of the Notes to the Condensed Consolidated Financial Statements.

See Accompanying Notes to Condensed Consolidated Financial ~~Statements.~~Statements

-2-

Table of Contents

ISC8 INC.

CONDENSED CONSOLIDATED STATEMENTS OF ~~CASH FLOWS~~COMPREHENSIVE LOSS

~~(Unaudited)~~(unaudited)

   13 Weeks Ended
   December 30, 2012 January 1, 2012
Cash flows from operating activities:
Net loss    $ (2,164,000 ) $ (8,250,000 )
Add: loss from discontinued operations    - 223,000
Loss from continuing operations    (2,164,000 ) (8,027,000 )

Adjustments to reconcile loss from continuing operations to net cash used in operating activities:
Depreciation and amortization    184,000    174,000
Non-cash interest expense    1,674,000    1,465,000
Change in fair value of derivative liability    (4,947,000 )   2,310,000
Non-cash stock-based compensation    235,000    836,000
Decrease in accounts receivable    38,000    158,000
(Increase) in unbilled revenues on uncompleted contracts    (93,000 ) (160,000 )
(Increase) in prepaid expenses and other assets    (70,000 ) (181,000 )
Increase (decrease) in accounts payable and accrued expenses    312,000    674,000
(Decrease) in Executive Salary Continuation Plan liability    (1,000 )   (15,000 )
Increase (decrease) in advance billings on uncompleted contracts    (19,000 ) 12,000
(Decrease) in deferred revenue    (42,000 )   -
Total adjustments    (2,729,000 )   5,273,000
Net cash used in operating activities    (4,893,000 ) (2,754,000 )
Cash flows from investing activities:
Property and equipment expenditures    (53,000 ) (49,000 )
Net cash paid related to acquisition of Bivio    (569,000 ) -
Net cash used in investing activities    (622,000 ) (49,000 )
Cash flows from financing activities:
Proceeds from senior subordinated secured convertible promissory notes    4,210,000    -
Proceeds from revolving credit line    -    5,000,000
Debt issuance costs paid    - (135,000 )
Principal payments of notes payable and settlement agreements    (4,000 ) (2,297,000 )
Principal payments of capital leases    (4,000 ) (2,000 )
Net cash provided by financing activities    4,202,000    2,566,000
Cash flows from discontinued operations:
Operating cash flows    - (158,000 )
Investing cash flow    -    (263,000 )
Net cash used in discontinued operations    -    (421,000 )

Effect of foreign currency translation    2,000 -
Net decrease in cash and cash equivalents    (1,311,000 )   (658,000 )
Cash and cash equivalents at beginning of period    1,738,000    2,735,000
Cash and cash equivalents at end of period    $ 427,000    $ 2,077,000

Non-cash investing and financing activities:
Non-cash conversion of preferred stock to common stock    $ -    $ 90,000
Conversion of Subordinated Secured Convertible Promissory Notes and accrued interest to common stock    $ 30,000    $
Common stock issued to pay accrued interest and board fees    $ 483,000    $ -
Issuance of warrants to acquire Bivio Software assets    $ 85,000    $ -
Senior subordinated secured promissory notes issued to settle accrued interest    $ 143,000    $ -
Issuance of warrants in connection with the Forbearance agreements    $ 324,000    $ -
Supplemental cash flow information:
Cash paid for interest    $ 152,000    $ 134,000
Cash paid for income taxes    $ 3,000    $ 3,000

	Quarter Ended
	December 31, 2013			December 31, 2012
Net loss	$	(513,000	)	$	(2,164,000	)
Other comprehensive loss before tax from continuing operations:
Foreign currency translation adjustments, net of $0 tax		(146,000	)		-
Comprehensive loss	$	(659,000	)	$	(2,164,000	)

See Accompanying Notes to Condensed Consolidated Financial ~~Statements.~~Statements

-3-

Table of Contents

ISC8 INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

	Quarter Ended
	December 31, 2013				December 31, 2012 (1) (2)
Cash flows from operating activities:
Net loss	$	(513,000	)	$	(2,164,000	)
(Income) loss from discontinued operations		-			(834,000	)
Loss from continuing operations		(513,000	)		(1,330,000	)
Adjustments to reconcile loss from continuing operations to net cash used in operating activities:
Depreciation and amortization		168,000			97,000
Provision for bad debt		83,000			-
Non-cash interest expense		3,448,000			1,674,000
Gain on extinguishment of debt		(316,000	)		-
Change in fair value of derivative liability		(7,334,000	)		(4,947,000	)
Non-cash stock-based compensation		1,535,000			235,000
Loss on disposal of property and equipment		4,000			-
Changes in assets and liabilities:
Accounts receivable		36,000			-
Prepaid expenses and other current assets		(45,000	)		(124,000	)
Other assets		181,000			-
Accounts payable and accrued expenses		255,000			654,000
Deferred revenue		(87,000	)		(42,000	)
Executive Salary Continuation Plan liability		(15,000	)		(1,000	)
Net cash used in operating activities		(2,600,000	)		(3,784,000	)

Cash flows from investing activities:
Property and equipment expenditures		-			(53,000	)
Net cash paid related to acquisition of Bivio		-			(569,000	)
Net cash used in investing activities		-			(622,000	)
		-
Cash flows from financing activities:
Proceeds from unsecured convertible promissory notes		200,000			4,210,000
Proceeds from Series D Convertible Preferred Stock		4,440,000			-
Proceeds from warrants exercised		6,000			-
Debt issuance costs paid		(132,000	)		-
Net change in deposit on PFG credit line		500,000			-
Principal payments on PFG credit line		(2,000,000	)		-
Principal payments on notes payable		(25,000	)		(4,000	)
Principal payments on capital leases		(103,000	)		(4,000	)
Net cash provided by financing activities		2,886,000			4,202,000

Cash flows from discontinued operations:
Net cash used in operating activities		(49,000	)		(1,109,000	)
Net cash used in discontinued operations		(49,000	)		(1,109,000	)
Effect of exchange rate changes on cash		2,000			2,000
Net increase (decrease) in cash and cash equivalents		239,000			(1,311,000	)
Cash and cash equivalents at beginning of period		136,000			1,738,000
Cash and cash equivalents at end of period	$	375,000		$	427,000

Non-cash investing and financing activities:
Equipment financed with capital leases	$	80,000		$	-
Conversion of notes and accrued interest to Series D Preferred stock	$	23,056,000		$	-
Conversion of notes to restricted stock	$	14,503,000		$	-
Employee stock based plan contribution	$	272,000		$	-
Conversion of notes and accrued interest to common stock	$	-		$	30,000
Common stock issued to pay accrued interest	$	487,000		$	483,000
Issuance of warrants to acquire Bivio Software assets	$	-		$	85,000
Senior Subordinated Note issued to settle accrued interest	$	-		$	143,000
Issuance of warrants in connection with Forbearance agreements		33,000			324,000

Supplemental cash flow information:
Cash paid for interest	$	149,000		$	152,000
Cash paid for income taxes	$	3,000		$	3,000

(1) In March 2013, the Company ceased operations of its government focused business, including Secure Memory Systems, Cognitive Systems and Microsystems business units (the “Government Business”). In accordance with the provisions of the Presentation of Financial Statements Topic 205 of the Accounting Standards Codification (“ASC”), the assets and liabilities related to the Government Business are now presented as discontinued operations for all periods presented in the consolidated financial statements. See Note 13 of the Notes to the Condensed Consolidated Financial Statements.

(2) On June 28, 2013, The Company changed its fiscal year end-date from the last Sunday of September to September 30. Accordingly, the first fiscal quarter of 2012 was previously reported as December 30, 2012. We did not change its prior period presentation to reflect the change in fiscal year as the difference is not material. See Note 1 of the Notes to the Condensed Consolidated Financial Statements.

See Accompanying Notes to Condensed Consolidated Financial Statements

-4-

Table of Contents

ISC8 INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~(Unaudited)~~(unaudited)

Note 1 — General

The information contained in the following Notes to Condensed Consolidated Financial Statements is ~~condensed~~derived from that which appears in the ~~audited~~accompanying unaudited condensed consolidated financial statements for ISC8 Inc. (“ISC8”), and its subsidiaries (together with ISC8, the “Company”), and ~~the accompanying unaudited condensed consolidated financial statements~~ do not include certain financial presentations normally required under accounting principles generally accepted in the United States of America (“GAAP”). Accordingly, the unaudited condensed consolidated financial statements included herein should be read in conjunction with the audited consolidated financial statements and related notes contained in the Company's Annual Report on Form 10-K ~~of the Company~~ for the fiscal year ended September 30, ~~2012~~2013 (“Fiscal ~~2012~~2013”), filed with the SEC on December 24, 2013, including the risk factors contained therein, as updated in ~~our~~this Quarterly Report on Form 10-Q for the quarter ended December ~~30, 2012.~~31, 2013. It should be understood that accounting measurements at interim dates inherently involve greater reliance on estimates than at year-end. The results of operations for the interim periods presented are not necessarily indicative of the results expected for the entire year.

The consolidated financial information for the ~~13-week~~three month periods ended December ~~30, 2012~~31, 2013 and ~~January 1,~~ 2012 included herein is unaudited but includes all normal recurring adjustments which, in the opinion of management, are necessary to present fairly the consolidated financial position of the Company at December ~~30, 2012,~~31, 2013, and the results of its operations and its cash flows for the ~~13-week period~~three month periods ended December ~~30, 2012~~31, 2013 as compared to the same period ended ~~January 1,~~December 31, 2012.

The accompanying September 30, 2013 balance sheet was derived from the audited fiscal 2013 financial statements.

Recent Developments

Creation of Series D Convertible Preferred. On October 30, 2013, the Company filed the Certificate of Designations of Rights, Preferences, Privileges and Limitations of the Series D Convertible Preferred Stock (the "Certificate of Designations") with the Delaware Secretary of State to designate 4,000 shares of the Company's preferred stock as Series D Convertible Preferred Stock ("Series D Preferred"). The Series D Preferred votes alongside shares of the Company's common stock, par value $0.01 per share (“Common Stock”), on an as converted basis, and ranks junior to the Company's Series B Convertible Cumulative Preferred Stock, but is senior to all other classes of the Company's preferred stock. Each share of Series D Preferred has a stated value of $10,000 (the "Stated Value"), and is currently convertible, at the option of the holder, into that number of shares of Common Stock equal to the Stated Value divided by the Conversion Price set forth in the Certificate of Designations (the "Conversion Shares").

Series D Preferred Financing. On October 31, 2013, the Company ~~sold its thermal imaging business, consisting~~accepted subscription agreements from certain accredited investors (the "Investors") to purchase shares of Series D Preferred (the "Series D Offering") for $10,000 per share. As additional consideration, each Investor received one-year warrants to purchase 59,523 shares of Common Stock for $0.084 per share ("Warrant Shares") for every share of Series D Preferred purchased (the "Series D Warrants"). Through December 31, 2013, investors have purchased 452 shares of Series D Preferred, resulting in gross proceeds of approximately $4.52 million.

Cancellation of Debt. In connection with the offer and sale of the Series D Preferred, certain holders of the Company's outstanding senior convertible debt agreed to exchange such debt, in the aggregate total of approximately $23.1 million in principal and accrued interest, for shares of Series D Preferred and Series D Warrants on substantially similar terms to the Series D Offering (the “Senior Note Conversion”). Upon execution of definitive documents, the Senior Note Conversion will result in the issuance of approximately 2,300 shares of Series D Preferred and Series D Warrants to purchase approximately 137.2 million shares of Common Stock. Furthermore, certain holders of the Company’s ~~business~~junior subordinated convertible debt agreed to exchange an aggregate total of ~~researching, developing, designing, manufacturing, producing, marketing, selling~~approximately $14.5 million in principal and ~~distributing thermal camera products, including clip-on thermal imagers, thermal handheld and mounted equipment devices, other infrared imaging devices and thermal cameras, and~~accrued interest for approximately 101.4 million shares of restricted Common Stock that vests in ~~all cases, related thermal imaging products~~the event the trading price of the Company’s Common Stock reaches $0.143 (the “~~Thermal Imaging Business”), to Vectronix, Inc. (“Vectronix”) on January 31, 2012 (the “Thermal Imaging Asset Sale”) pursuant to an Asset Purchase Agreement dated October 17, 2011 between the Company and Vectronix (the “Thermal Imaging APA~~Junior Note Conversion”). The operations of the Thermal Imaging Business are presented as discontinued operations. To provide comparability between the periods, the consolidated financial information for the 13-week period ended January 1, 2012 has been reclassified to reflect the Company’s results of continuing operations excluding the Thermal Imaging Business.

The condensed consolidated financial information as of September 30, 2012 included herein is derived from the Company’s audited consolidated financial statements as of, and for the year ended, September 30, 2012.

~~Description of Business~~

The Company is actively engaged in the design, development, manufacture and sale of security products, particularly cyber security solutions for government and commercial applications, utilizing technologies we pioneered for three-dimensional (“~~3-D~~”) stacking of various products including semiconductors, anti-tamper systems, high-speed processor assemblies, and miniaturized vision systems and sensors. The Company also performs customer-funded contract research and development related to these products, mostly for U.S. Government customers or other prime contractors.

~~Acquisition of Bivio Software~~

~~On October 12, 2012, pursuant to the terms of the Foreclosure Sale Agreement between the Company and GF Acquisition Co. 2012, LLC (“GFAC”) dated October 4, 2012 (the “Foreclosure Sale Agreement~~”), the Company acquired substantially all of the assets of the NetFalcon and the Network Content Control System Business of Bivio Networks, Inc. and certain of its subsidiaries, an international provider of cyber security solutions and products (“~~Bivio” or “Bivio Software~~”). The purchase price was $600,000 payable in cash to GFAC, and the issuance to GFAC of a warrant to purchase 1,000,000 shares of common stock of the Company at the lower of $0.12 or the price of a future equity financing (“~~Bivio Warrant”). In addition, the Company assumed certain liabilities, including accounts payable, contractual obligations, reclamation obligations and other liabilities related to Bivio Software.~~

~~-4-~~

~~Table of Contents~~

~~Summary of Significant Accounting Policies~~

~~Revenues.~~ We primarily derive our revenues from three sources, (i) contracts to develop prototypes and provide research, development, design, testing and evaluation of complex detection and control defense systems, (ii) product sales, and (iii) cyber related software revenue.

~~Research and Development Contracts~~

This segment relates primarily to our Government contracting business, our cyber products and some of our Secure Memory products which are funded internally and are part of our operating expense. The terms of our government research and development contracts are usually cost reimbursement plus a fixed fee, fixed price with billing entitlements based on the level of effort we expend, or occasionally firm fixed price. Our cost reimbursement plus fixed fee research and development contracts require our good faith performance of a statement of work within overall budgetary constraints, but with latitude as to resources utilized. Our fixed price level of effort research and development contracts require us to deliver a specified number of labor hours in the performance of a statement of work. Our firm fixed price research and development contracts require us to deliver specified items of work independent of resources utilized to achieve the required deliverables. For all types of research and development contracts, we recognize revenues as we incur costs and include applicable fees or profits primarily in the proportion that costs incurred bear to estimated final costs. Costs and estimated earnings in excess of billings under U.S. government research and development contracts are accounted for as unbilled revenues on uncompleted contracts, stated at estimated realizable value and are expected to be realized in cash within one year.

Upon the initiation of each research and development contract, a detailed cost budget is established for direct labor, material, subcontract support and allowable indirect costs based on our proposal and the required scope of the contract as may have been modified by negotiation with the customer, usually a U.S. government agency or prime contractor. A program manager is assigned to secure the needed labor, material and subcontract in the program budget to achieve the stated goals of the contract and to manage the deployment of those resources against the program plan. Our accounting department collects the direct labor, material and subcontract charges for each contract and provides such information to the respective program managers and senior management.

The program managers review and report the performance of their contracts against the respective program plans with our senior management on a monthly basis. These reviews are summarized in the form of estimates of costs to complete the contracts (“~~ETCs~~”). If an ETC indicates a potential overrun against budgeted program resources, it is the responsibility of the program manager to revise the program plan in a manner consistent with the customer’s objectives to eliminate such overrun and achieve planned contract profitability, and to seek necessary customer agreement to such revision. To mitigate the financial risk of such re-planning, we attempt to negotiate the deliverable requirements of our research and development contracts to allow as much flexibility as possible in technical outcomes. Given the inherent technical uncertainty involved in research and development contracts, in which new technology is being invented, explored or enhanced, such flexibility in terms is frequently achievable. When re-planning does not appear possible within program budgets, senior management makes a judgment as to whether the program statement of work will require additional resources to be expended to meet contractual obligations or whether it is in our interest to supplement the customer’s budget with our own funds. If either determination is made, we record an accrual for the anticipated contract overrun based on the most recent ETC of the particular contract.

We provide for anticipated losses on contracts by recording a charge to earnings during the period in which a potential for loss is first identified. We adjust the accrual for contract losses quarterly based on the review of outstanding contracts. Upon completion of a contract, we reduce any associated accrual of anticipated loss on such contract as the previously recorded obligations are satisfied.

-5-

Table of Contents

Modification of PFG Loan Agreement. On November 1, 2013, the Company substantially modified its Loan Agreement with Partners for Growth III, L.P. (“PFG”) to provide, among other things, for a one-year extension of the maturity date under the Loan Agreement to December 31, 2014 (the “PFG Loan Modification”). In return, the Company made a $2.0 million repayment on the loan, deposited $500,000 with PFG as collateral for the loan, and, in the event the Company consummates a debt or equity financing, the Company agreed to pay to PFG 25% of the proceeds from such financing. PFG and the Company also modified the Guaranty Agreement executed in connection with the Loan Agreement in order to: (i) release Costa Brava Partnership III, LP (“Costa Brava”) from its guarantee of the Company's debt to PFG, (ii) reduce the maximum guarantee amount to $1.0 million, and (iii) affirm the obligations of the Griffin Fund LP (“Griffin”) under the Guaranty Agreement.

~~We consider many factors when applying GAAP related~~ Amendments to ~~revenue recognition. These factors generally include, but are not limited to:~~

	•	~~The actual contractual terms, such as payment terms, delivery dates, and pricing terms of the various product and service elements of a contract;~~
	•	~~Time period over which services are to be performed;~~
	•	~~Costs incurred to date;~~
	•	~~Total estimated costs of the project;~~
	•	~~Anticipated losses on contracts; and~~
	•	~~Collectability of the revenues.~~

~~We analyze each~~Articles of Incorporation or Bylaws. On October 31, 2013, the Company amended Article III, Section 2 of the ~~relevant factors~~Company's Bylaws to ~~determine~~decrease the fixed number of directors from ten to seven (the "Bylaw Amendment").

Increase of Authorized Number of Common Shares. On January 16, 2014, the Company filed with the Delaware Secretary of State an amendment to its ~~impact, individually and collectively with other factors, on~~Certificate of Incorporation to the revenue to be recognized for any particular contract with a customer. Our management is required to make judgments regarding the significance of each factor in applying the revenue recognition standards, as well as whether or not each factor complies with such standards. Any misjudgment or error by our management in evaluationincrease of the ~~factors and the application~~total number of ~~the standards could have a material adverse effect on our future operating results.~~

~~Product Sales~~

~~Our revenues derived~~authorized shares of capital stock from ~~product sales are primarily the result~~801,000,000 to 2,001,000,000, of ~~shipments of our stacked chip products. Production orders~~which 2,000,000,000 will be available for ~~our products are generally priced in accordance with established price lists. We primarily ship stacked chip products to original equipment manufacturers (“~~issuance as Common Stock (the “~~OEMs~~Amendment”).

~~We recognize revenue from product sales upon shipment, provided that the following conditions are met:~~

	•	~~There are no unfulfilled contingencies associated with the sale;~~
	•	~~We have a sales contract or purchase order with the customer; and~~
	•	~~We are reasonably assured that the sales price can be collected.~~

~~The absence of any of these conditions, including~~ Amendment to 2011 Omnibus Incentive Plan and Option Exchange Program. On January 16, 2014, the ~~lack of shipment, would cause revenue recognition~~Company implemented an amendment to ~~be deferred. Our terms are freight on board (“~~its 2011 Omnibus Incentive Plan (the “~~FOB~~2011 Plan”) ~~shipping point. We record product support expenses incurred~~to increase the number of shares of Common Stock issuable under the 2011 Plan to 446,500,000 (the “Plan Amendment”). In October 2013, in anticipation of stockholder approval of the Plan Amendment, the Company commenced an option exchange program (the “Option Exchange Program”) wherein holders of stock options previously issued under the Company’s equity compensation plans could, at the option of the holder, exchange outstanding options for new options to purchase shares of Common Stock for $0.042 per share. To date, the Company has canceled outstanding stock options to purchase 28.6 million shares of Common Stock, and ~~accrue such expenses expected~~issued new options under the 2011 Plan to ~~be incurred in relation to shipped products. We do not offer contractual price protection on any~~purchase approximately 146.9 million shares of ~~our products. Accordingly, we do not maintain any reserves~~Common Stock for post-shipment price adjustments. We do not utilize distributors for the sale of our products, but we are engaged with channel partners that act as an extension of our internal sales team. We do not enter into revenue transactions in which the customer has the right to return product. Accordingly, we do not make any provisions for sales returns or adjustments in the recognition of revenue.$0.042 per share.

~~-6-~~

~~Table~~ New Location Established as ISC8 Malaysia. On October 28, 2013, the Company announced the opening of ~~Contents~~

~~Cyber Related Software Revenue~~

The Company generates revenue from the sale of licensing rights to its software products directly to end-users and through value-added resellers, or VARs. The Company also generates revenue from sales of hardware, installation, and post contracta new office in Kuala Lumpur, Malaysia in support ~~(maintenance), performed for clients who license its products. A typical system contract contains multiple elements~~ of the ~~above items. Revenue earned on software arrangements involving multiple elements is allocated to each element based on the fair values~~projected growth of ~~those elements. The fair value of an element is based on vendor-specific objective evidence~~business within South East Asia (“~~VSOE~~ISC8 Malaysia”). The Company limits its assessment of VSOE for each element to either the price charged when the same element is sold separately or the price established by management having the relevant authority to do so, for an element not yet sold separately. VSOE calculations are updated and reviewed quarterly or annually depending on the nature of the product or service. When evidence of fair value existsISC8 Malaysia will serve as a regional hub for the ~~delivered and undelivered elements of a transaction, then discounts for individual elements are aggregated and~~Company in the ~~total discount is allocated to the individual elements~~multi-billion dollar market in proportion to the elements' fair value relative to the total contract fair value. When evidence of fair value exists for the undelivered elements only, the residual method is used. Under the residual method, The Company defers revenue related to the undelivered elements based on VSOE of fair value of each of the undelivered elements and allocates the remainder of the contract price net of all discounts to revenue recognized from the delivered elements. If VSOE of fair value of any undelivered element does not exist, all revenue is deferred until VSOE of fair value of the undelivered element is established or the element has been delivered.South East Asia.

Summary of Significant Accounting Policies

~~For arrangements that include both software and non-software elements, we allocate revenue~~ There have been no significant changes to the ~~software deliverables and non-software deliverables based~~Company’s significant accounting policies during the three months ended December 31, 2013. See Note 1 to the Company’s Consolidated Financial Statements included in the Company’s 2013 Annual Report on ~~their relative selling prices. In such circumstances,~~Form 10-K, filed with the ~~accounting principles establish~~SEC on December 24, 2013, for a ~~hierarchy to determine the selling price to be used for allocating revenue to deliverables as follows: (i) VSOE, (ii) third-party evidence of selling price ("TPE") and (iii) best estimate~~comprehensive description of the ~~selling price ("ESP"). When we are unable to establish a selling price using VSOE, or TPE, we use ESP to allocate the arrangement fees to the deliverables.~~Company’s significant accounting policies.

Provided the fees are fixed or determinable and collection is considered probable, revenue from licensing rights and sales of hardware and third-party software is generally recognized upon physical or electronic shipment and transfer of title. In certain transactions where collection risk is high, the revenue is deferred until collection occurs or becomes probable. If the fee is not fixed or determinable, then the revenue recognized in each period (subject to application of other revenue recognition criteria) will be the lesser of the aggregate of amounts due and payable or the amount of the arrangement fee that would have been recognized on a straight line basis over the contractual period.

Consolidation. The consolidated financial statements include the accounts of ISC8 and its subsidiaries, ~~ISC8 Europe Limited,~~ Novalog, Inc. (“Novalog”), MicroSensors, Inc. (“MSI”), RedHawk Vision Systems, Inc. (“RedHawk”) ~~and~~ iNetWorks Corporation (“iNetWorks”)~~. As of December 30, 2012, of~~, ISC8 Europe Limited (“ISC8 Europe”) and ISC8 Malaysia SDN.BMD. Of the Company’s subsidiaries, only ISC8 Europe ~~Limited had material operations~~presently has operating activities and assets, ~~and had~~ separate employees and facilities. All significant intercompany transactions and balances ~~were~~have been eliminated in the consolidation. None of the Company’s subsidiaries accounted for more than 10% of the Company’s total assets at December 31, 2013 or December 31, 2012.

~~Fiscal Periods~~ Reclassifications. ~~. The Company’s fiscal~~Certain amounts in the consolidated financial statements have been reclassified in order to conform to the current year ~~ends on the Sunday nearest September 30. Fiscal 2012 ended on September 30, 2012 and consisted of 52 weeks. The fiscal year ending September 29, 2013 (“Fiscal 2013”) will consist of 52 weeks. The Company’s first quarter of Fiscal 2013 consisted of 13 weeks ended December 30, 2012.~~presentation.

Reportable Segments. The Company is presently managing its continuing operations as a single business segment. The Company is continuing to evaluate the current and potential business derived from sales of its products and, in the future, may present its consolidated statement of operations in more than one segment if the Company segregates the management of various product lines in response to business and market conditions.

~~Goodwill and Other Intangible Assets~~. The Company acquired goodwill as a result of its purchase of Bivio Software. As a result, we will test goodwill for impairment annually at the end of the third fiscal quarter, referred to as the annual test date. The Company will also test for impairment between annual test dates if an event occurs or circumstances arise that would indicate the carrying amount may be impaired. Goodwill impairment testing is performed as a single reporting unit.

~~-7-~~-6-

Table of Contents

Discontinued Operations. On March 19, 2013, the Company discontinued its government-focused business, including the Secure Memory Systems, Cognitive and Microsystems business units (the “Government Business”), to focus on the Company’s cyber-security business. The Company's former Vice Chairman and Chief Strategist, John Carson, who originally founded the Government Business, has formed Irvine Sensors Corporation, an unrelated entity, to continue the Government Business.

The ~~first step~~results of operations and the assets of the ~~impairment test involves comparing~~Government Business are now presented as discontinued operations in the ~~fair values~~consolidated financial statements through the date of dissolution, as applicable, in accordance with the provisions of the ~~single reporting unit with its carrying value. If the carrying amount~~Presentation of Financial Statements Topic 205 of the ~~single reporting unit exceeds its fair value, we perform~~Accounting Standards Codification (“ASC”). To provide comparability between the ~~second step~~periods, the consolidated financial information for all periods presented has been reclassified to reflect the Company’s results of continuing operations. See Note 8 below.

Change in Fiscal Year End-Date. On June 28, 2013, the ~~goodwill impairment test. The second step~~Company’s Board of Directors unanimously approved a change to the ~~goodwill impairment test involves comparing~~Company’s fiscal year end-date from the ~~implied fair value~~last Sunday of September to September 30. Accordingly, Fiscal 2013 ended on September 30, 2013, rather than September 29, 2013. Although the ~~single reporting unit’s goodwill with the carrying value~~first fiscal quarter of ~~that goodwill. The amount by which the carrying value of the goodwill exceeds its implied fair value, if any, is recognized~~2012 was previously reported as ~~an impairment loss. As of~~ December 30, 2012, ~~we have~~the Company did not ~~identified any events or circumstances that would require an interim goodwill impairment test.~~change its prior period presentation reflecting the current change in fiscal year because the difference is immaterial.

~~Intangible assets with definite lives at December 30, 2012 consist principally~~ Use of ~~software technology, trade names, and customer relationship, which were acquired as a result~~Estimates. The preparation of the ~~business combination~~financial statements in conformity with ~~Bivio Software. These assets are amortized on a straight-line basis over their estimated useful lives.~~

~~Derivatives.~~ A derivative is an instrument whose value is “derived” from an underlying instrument or index such as a future, forward, swap, option contract, or other financial instrument with similar characteristics, including certain derivative instruments embeddedaccounting principles generally accepted in ~~other contracts~~the United States of America (“~~Embedded Derivatives~~GAAP”) and for hedging activities. As a matter of policy, the Company does not invest in separable financial derivatives or engage in hedging transactions. However, the Company has entered into complex financing transactions that involve financial instruments containing certain features that have resulted in the instruments being deemed derivatives or containing Embedded Derivatives. The Company may engage in other similar complex debt transactions in the future, but not with the intentionrequires management to enter into derivative instruments. Derivatives and Embedded Derivatives, if applicable, are measured at fair value using the Binomial Lattice pricing model and marked to market through earnings. However, such new and/or complex instruments may have immature or limited markets. As a result, the pricing models used for valuation of derivatives often incorporate significantmake estimates and assumptions ~~which may impact~~that affect the ~~level of precision~~amounts reported in the financial ~~statements. Furthermore, depending on the terms~~statements and accompanying notes. Actual results could differ from those estimates. Management prepares estimates for a number of afactors, including derivative ~~or Embedded Derivative, the~~liability, stock-based compensation, warrants valuation, revenue recognition, valuation of ~~derivatives may~~goodwill and other intangible assets, allowance for doubtful accounts and notes receivable, and deferred tax assets and liabilities. The Company believes its estimates of derivative liabilities, and warrants valuation to be ~~removed from~~ the most sensitive estimates impacting financial ~~statements upon conversion~~position and results of operations in the ~~underlying instrument into some other security or the terms of the underlying instrument becoming fixed.~~near term.

Subsequent Events. Management has evaluated events subsequent to December ~~30, 2012~~31, 2013 through the date ~~the accompanying consolidated financial statements were filed with the Securities and Exchange Commission~~of this Quarterly Report on Form 10-Q for transactions and other events that may require adjustment of and/or disclosure in such financial ~~statements, and other than described, have determined that there are no~~statements. See Note 12 for a discussion of events occurring subsequent ~~events that require disclosure.~~to December 31, 2013.

Note 2 – Revolving Credit Facility Repayment

During July 2013, Costa Brava deposited $1.0 million into an escrow account held by PFG (the “PFG Guarantee Fund”), which was used for the partial repayment of the $5.0 million revolving credit facility issued by PFG to the Company in December 2011 (the “Revolving Credit Facility”). Costa Brava irrevocably transferred the rights, title and interest of the PFG Guarantee Fund to the Company. In exchange for funding the PFG Guarantee Fund, the Company issued a $1.0 million Senior Secured Convertible Note (defined below) to Costa Brava. In October 2013, the Company deposited $1.5 million of the proceeds received from the Series D Offering into the PFG Guarantee Fund, and, in turn, made a $2.0 million payment on the Revolving Credit Facility, leaving the Revolving Credit Facility with a $3.0 million outstanding balance.

Note 3 – Going Concern

The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and settlement of obligations in the normal course of business. The Company generated significant net losses in previous fiscal years. ~~In Fiscal~~For the three months ended December 31, 2013 and 2012, the Company had a ~~net~~ loss from continuing operations of ~~$19.7 million.~~$0.5 million and $1.3 million, respectively. As of December 31, 2013 and September 30, ~~2012,~~2013, the Company also had negative working capital of approximately $6.5 million and $29.7 million, and stockholders’ deficit of ~~approximately $16.0~~$6.4 million and ~~$36.2~~$55.6 million, respectively.

Management believes that the Company’s losses in recent years have primarily been ~~primarily~~ the result of increased research and development expenditures related to the cyber technology and efforts to productize those technologies and bring them to market. These losses were augmented by insufficient revenue to support the Company’s skilled and diverse technical staff, ~~which is~~who are considered necessary to support commercialization of the Company’s technologies. Unsuccessful commercialization efforts in past fiscal years have contributed to the stockholders’ deficit as of December ~~30, 2012. As~~31, 2013.

-7-

Table of December 30, 2012, we expended a large portion of the cash obtained from the Thermal Imaging Sale, the Revolving Credit Facility (defined below), and 2012 Notes (defined below) to fund our operations.Contents

Management is focused on managing costs in line with estimated total revenues, including contingencies for cost reductions if projected revenues are not fully realized. However, there can be no assurance that anticipated revenues will be realized or that the Company will be able to successfully implement its plans. Accordingly, the Company will need to raise additional funds to meet its continuing obligations in the near future and may incur additional future losses. However, there can be no assurance that suitable financing will be available on acceptable terms, on a timely basis, or at all. Failure to do so and meet the obligations of our existing debt could result in default and acceleration of debt maturity, which could materially adversely effect our business and financial condition, and ultimately threaten our viability as a going concern.

~~-8-~~

~~Table of Contents~~

The accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should the Company be unable to continue as a going concern.

Note 34 — Goodwill and Other Intangible Assets

The Company acquired goodwill as a result of its purchase of Bivio Software in October 2012. The Company tests goodwill for impairment annually during its third fiscal quarter, referred to as the annual test date. The Company will also test for impairment between annual test dates if an event occurs or circumstances arise that would indicate the carrying amount may be impaired. Goodwill impairment testing is performed as a single reporting unit.

Intangible assets with definite lives at December 31, 2013 consist principally of software technology, trade names, and customer relationship, which were acquired as a result of the business combination with Bivio Software in October 2012. These assets are amortized on a straight-line basis over their estimated useful lives. The Company will test for impairment between annual test dates if an event occurs or circumstances arise that would indicate the carrying amount may be impaired. There were no indications of impairment through December 31, 2013.

We do not believe there is a reasonable likelihood that there will be a material change in the future estimates and assumptions we use to test for impairment losses on goodwill and intangible assets. However, if actual results are not consistent with our estimates or assumptions, we may be exposed to future impairment charges that could be material.

-8-

Table of Contents

Note 5 — Debt Instruments

~~At December 30, 2012,~~ In October 2013, the Company ~~had~~implemented the ~~following~~Senior Note Conversion and Junior Note Conversion discussed above in Note 1, “Recent Developments”, and exchanged certain outstanding debt ~~instruments:~~totaling approximately $23.1 million in principal and accrued interest for shares of Series D Preferred, Series D Warrants and/or shares of restricted Common Stock (“Restricted Stock”). The following table summarizes the Senior Note Conversion and Junior Note Conversion activity during the quarter ended December 31, 2013:

	Principal balance at issuance date		Principal balance at December 30, 2012			Principle balance, net of unamortized discount at September 30, 2013		(Repayment) Proceeds			Debt converted into Series D Preferred			Debt converted to restricted Common Stock			Amortization/ extinguishment of debt discount		Principle balance, net of unamortized discount as of December 31, 2013
Senior Secured Revolving Credit Facility	$	5,000,000	$	5,000,000		$	4,908,000	$	(2,000,000	)	$	-		$	-		$	165,000	$	3,073,000
Senior Subordinated Secured Convertible Promissory Notes		5,410,000		5,410,000
Senior Subordinated Secured Convertible Promissory 2013 Notes							15,793,000		175,000			(16,199,000	)		-			1,841,000		1,610,000
Senior Subordinated Secured Promissory Notes		4,000,000		4,934,000			5,392,000		-			(5,392,000	)		-			-		-
Subordinated Secured Convertible Promissory Notes		15,051,200		16,092,000			8,570,000		-			(381,000	)		(14,357,000	)		6,950,000		782,000
Total Gross Debt							34,663,000		(1,825,000	)		(21,972,000	)		(14,357,000	)		8,956,000		5,465,000
Accrued interest converted to equitiy							-		-			(1,084,000	)		(146,000	)		-		-
Gross adjustment to paid-in capital(1)					Gross adjustment to paid-in capital(1)						$	(23,056,000	)	$	(14,503,000	)

(1) The net amount presented excludes the impact of unamortized debt discount, derivative liability and deferred issuance costs.

Senior Subordinated Secured Convertible Promissory 2013 Notes

Through October 31, 2013, we issued Senior Subordinated Secured Convertible Promissory Notes (the “Senior Subordinated Convertible Notes”) in the aggregate principal amount of $17.8 million to certain accredited investors, including Griffin. The Senior Subordinated Convertible Notes accrue interest at a rate of 12% per annum, and are secured by all of the Company’s assets. The Senior Subordinated Convertible Notes are convertible, at the option of each respective holder, into that number of shares of Common Stock equal to the outstanding principal and accrued interest of the Senior Subordinated Notes, divided by the conversion price set forth in the note (the “Conversion Price”). The Senior Subordinated Convertible Notes issued during Fiscal 2012 (the “2012 Notes”) had a Conversion Price of $0.12 per share, or the price of shares sold by us to one or more investors in a subsequent financing resulting in gross proceeds in excess of $1.0 million (a “Qualified Financing”). The Senior Subordinated Convertible Notes issued during Fiscal 2013 (the “2013 Notes”) have a floating price based on the next Qualified Financing. Since both the 2012 Notes and 2013 Notes have a floating conversion price, the embedded conversion feature was considered a derivative liability, and was bifurcated from the host until October 31, 2013 when the price was fixed at $0.042 as a result of the Series D Offering and the 2012 Notes and 2013 Notes were no longer considered derivatives.

-9-

Table of Contents

On October 31, 2013, pursuant to the Senior Note Conversion, Senior Subordinated Convertible Notes in the aggregate total of approximately $17.2 million of principal and accrued interest (the “Outstanding Balance”) were canceled and exchanged for approximately 1,720 shares of Series D Preferred. The Company accounted for the conversion of these Senior Subordinated Convertible Notes, which was deemed an extinguishment of debt, in one of two methods. For the Senior Subordinated Convertible Notes in the aggregate principal amount of $5.5 million held by investors not otherwise related to the Company, the Company removed the net carrying value of the debt, including accrued interest, deferred financing cost and the derivative liability, and recorded the fair value of the shares of Series D Preferred issued in exchange for the cancellation thereof. The resulting difference of $0.4 million was recognized as a gain on debt extinguishment. The remaining Senior Subordinated Convertible Notes in the aggregate total of $11.7 million, which notes were held by related parties, were accounted for as capital transactions whereby the net carrying value of the debt, including accrued interest, deferred financing cost and the derivative liability, totaling $13.1 million, was recorded as an increase to paid in capital.

During Fiscal 2013, the Company and each respective holder of remaining Senior Subordinated Convertible Notes, including those sold to clients of J.P. Turner & Company, L.L.C. (“J.P. Turner”), entered into an amendment to extend the maturity date of the notes to January 31, 2014 (the “Amended Senior Subordinated Convertible Notes”). As additional consideration for this extension, the Company issued warrants to those holders of the Amended Senior Subordinated Convertible Notes to purchase an aggregate total of 63.8 million shares of Common Stock for $0.001 per share. On December 6, 2013, holders of certain Amended Senior Subordinated Convertible Notes sold to clients of J.P. Turner in the aggregate principal amount of approximately $1.0 million notified the Company of their position that the Series D Offering meets the definition of a Qualified Financing, as such term is defined in the Amended Senior Subordinated Convertible Notes, and, as a result, the Amended Senior Subordinated Convertible Notes matured on November 1, 2013, a position the Company disputes. See Note 13 herein for further information regarding subsequent events relating to these Amended Senior Subordinated Convertible Notes.

As of December 31, 2013, $0.5 million of the outstanding Senior Subordinated Convertible Notes had matured. The Company is in the process of working with the respective holders of these notes to extend the maturity dates or convert the debt into shares Series D Preferred and Series D Warrants; however no assurances can be given that the Company will be successful in this effort. See Note 13 herein for further information regarding subsequent events relating to the Senior Subordinated Secured Convertible Notes.

Subordinated Secured Convertible Promissory Notes

In December 2010, the Company entered into a Securities Purchase Agreement with Costa Brava and Griffin, pursuant to which the Company issued and sold to Costa Brava and Griffin 12% Subordinated Secured Convertible Notes due December 23, 2015 (the “Subordinated Notes”) in the aggregate principal amount of $7.8 million and, in March 2011, the Company sold additional Subordinated Notes to Costa Brava and Griffin for an aggregate purchase price of $1.2 million. Subsequently, in July 2011, the Company sold Subordinated Notes to five accredited investors, including Costa Brava and Griffin, in the aggregate principal amount of $5.0 million. In addition, holders of certain of the Company’s then outstanding debt, with a principal balance of $1.1 million, converted such debt into Subordinated Notes during the year ended September 30, 2011.

As of December 31, 2013, the principal and accrued but unpaid interest of the remaining unconverted Subordinated Notes was convertible at the option of the holder into shares of Common Stock at an initial conversion price of $0.07 per share. The conversion price is subject to a full price adjustment feature for certain price dilutive issuances of securities by the Company, and proportional adjustment for events such as stock splits, dividends, combinations, etc., and as such, are considered to be derivatives. Upon completion of the Series D Offering, the conversion price was adjusted to $0.042 per share. The Company may force the conversion of the Subordinated Notes into Common Stock if certain customary equity conditions have been satisfied and the volume weighted average price of the Common Stock is $0.25 or greater for 30 consecutive trading days. As of December 31, 2013, the Company has not met the equity conditions to force the conversion of the Subordinated Notes.

On October 31, 2013, Subordinated Notes in the aggregate total of $14.5 million in principal and accrued interest due to Costa Brava and Griffin were cancelled in exchange for approximately 101.5 million shares of Restricted Stock. The Restricted Stock will vest in the event the trading price of the Company’s Common Stock reaches $0.143. Because the managing members of Costa Brava and Griffin served on the Company’s board of directors during the quarter ended December 31, 2013, Costa Brava and Griffin are related parties to the Company. As such, the canceled $14.5 million principal and accrued interest, and the related discount and derivative liability was treated as a contribution to paid in capital.

-10-

Table of Contents

Also, on October 31, 2013, the holder of a Subordinated Note totaling $0.4 million in principal and accrued interest, not otherwise related to the Company, exchanged such note for approximately 40 shares of Series D Preferred. The Company removed the net carrying value of the debt including accrued interest, deferred financing cost and the derivative liability, recorded the fair value of the Series D Preferred and the resulting difference of $37,000 was recognized as a loss on debt extinguishment.

As of December 31, 2013, Subordinated Notes in the aggregate principal amount of $1.4 million remain outstanding, of which $0.2 million mature during December 2015, $0.2 million mature during January 2016, $0.1 million mature during April 2016 and $0.9 million mature during July 2016. The balance of the unconverted Subordinated Notes, net of unamortized discounts at December 31, 2013 was $0.8 million. The debt discounts will be amortized over the term of the unconverted Subordinated Notes, unless such amortization is accelerated due to earlier conversion of the Subordinated Notes pursuant to their terms.

Senior Subordinated Secured Promissory Notes

In March 2011, the Company issued and sold 12% Senior Subordinated Secured Promissory Notes (the “Senior Subordinated Notes”) to two accredited, related party investors, Costa Brava and Griffin. In July 2011, the Senior Subordinated Notes were amended to permit the holders to demand repayment any time on or after July 16, 2012, in partial consideration for permitting the issuance of additional Subordinated Secured Convertible Promissory Notes. The Senior Subordinated Notes are secured by substantially all of our assets pursuant to Security Agreements dated March 16, 2011 and March 31, 2011 between the Company and Costa Brava as representative of the Senior Subordinated Note holders. However, the liens securing the Senior Subordinated Notes are subordinate to the liens securing the Company’s indebtedness to PFG under the Revolving Credit Facility. Interest is calculated by adding the amount of such interest to the outstanding principal amount of the Senior Subordinated Notes as paid-in-kind interest. As a result of the addition of such interest, the outstanding principal amount of the Senior Subordinated Notes at October 31, 2013 was $5.4 million.

On October 31, 2013, the outstanding balance was converted to approximately 545 shares of Series D Preferred. Since the note holders are related parties to the Company, the Company accounted for the conversion of these notes as a capital transaction whereby the net carrying value of the debt including accrued interest was recorded as an increase to contributed capital.

Priority of Outstanding Debt

As of December 31, 2013, our outstanding debt is ranked as follows: (i) the Revolving Credit Facility is senior to all other debt; (ii) the Senior Subordinated Convertible Notes and Subordinated Secured Notes rank pari passu with one another; and (iii) the Subordinated Notes rank junior to all other debt.

Revolving Credit Facility

In December 2011, the Company entered into athe Loan ~~and Security~~ Agreement ~~(the “Loan Agreement~~”) with ~~Partners for Growth III, L.P. (“~~PFG~~”) pursuant~~ to ~~which~~obtain the ~~Company obtained a two-year, $5,000,000 revolving credit facility from PFG (the “~~Revolving Credit ~~Facility”).~~Facility. As additional consideration for entering into the Revolving Credit Facility, the Company issued to PFG and two PFG affiliated entities 7-year warrants to purchase, for $0.11 per share, an aggregate of ~~15,000,000~~15.0 million shares of the Company’s ~~common stock~~Common Stock (the “PFG Warrants”).

The Revolving Credit Facility was originally set to mature on December 14, 2013, however, in connection with the PFG Loan Modification, the maturity date ~~for~~was extended to December 31, 2014. Interest on the Revolving Credit Facility ~~is December 14, 2013 (the “Maturity Date”). Interest on the loan~~ accrues at the rate of 12% per annum, payable monthly, with the ~~remaining~~principal balance payable on the Maturity Date. ~~Each~~See Note 1 above and Note 13 below for further discussion of ~~Costa Brava Partnership III L.P. (“Costa Brava~~”)events during and ~~The Griffin Fund LP (“Griffin”), major stockholders and debt holders of~~subsequent to the ~~Company, individually and collectively, jointly and severally, have unconditionally guaranteed repayment~~quarter ended December 31, 2013 related to ~~PFG of $2,000,000 of~~ the ~~Company’s monetary obligations under the Loan Agreement.~~Revolving Credit Facility.

To secure the payment of the Company’s obligations under the Loan Agreement, the Company granted to PFG a first position, continuing security interest in substantially all of the Company’s assets, including substantially all of its intellectual property. In addition, Costa Brava, Griffin and certain other existing creditors of the Company have agreed that, while any obligations remain outstanding by the Company to PFG under the Loan Agreement, their security interests in and liens on the Company’s assets shall be subordinated and junior to those of PFG.

As of December 30, 2012, the Company was not in compliance with the financial covenants in the Loan Agreement and Revolving Credit Facility. On August 21, 2012, the Company and PFG entered into a Forbearance, Limited Waiver and Consent under Loan Agreement (the “~~Waiver~~”) by which, subject to certain terms and conditions, PFG waived that default and consented to other actions taken or to be taken by the Company, including the issuance of securities to finance the acquisition of Bivio. The Company agreed to pay to PFG a $30,000 fee and issue to PFG warrants to purchase 2,045,045 shares of common stock (the “~~Waiver Warrants”). The exercise price of the Waiver Warrants was equal to the effective price of the next equity financing completed by December 31, 2012 or $0.11 per share.~~

~~-9-~~

~~Table of Contents~~

The Waiver, by its terms, expired on September 30, 2012. As of September 28, 2012, in light of the Company’s continuing non-compliance with the financial covenants in the Loan Agreement, the Company and PFG entered into an Extension of Forbearance under Loan and Security Agreement (the “~~Forbearance Extension”). In consideration of granting the Forbearance Extension, the Company issued to PFG a warrant to purchase 2,045,045 shares of common stock (the “Extension Waiver Warrants~~”). The exercise price of the Extension Waiver Warrants was equal to the effective price of the next equity financing completed by December 31, 2012 or $0.11 per share. On October 31, 2012 the Company obtained a second forbearance extension (the “~~Second Forbearance~~”) from PFG which remained in effect until October 31, 2012 and subsequently extended to remain in effect until December 15, 2012. The Company and PFG entered into a third forbearance extension (the “~~Third Forbearance~~”) that extended PFG’s forbearance until January 31, 2013. As compensation for the Second Forbearance and the Third Forbearance the Company issued to PFG Extension Waiver Warrants to purchase an additional 4,090,910 shares of common stock with the same terms as above. Since the exercise price of the Second and Third Forbearance Warrants were not fixed, such instrument was considered to be a derivative. As such, the Company recorded approximately $324,000 as a derivative liability and expensed the cost of these warrants as interest expense. The Company and PFG entered into a fourth forbearance extension (the “~~Fourth Forbearance~~”) that extended PFG’s forbearance until February 28, 2013. As compensation for the Fourth Forbearance, the Company issued to PFG Extension Waiver Warrants to purchase an additional 2,045,455 shares of common stock.

~~The Company classified the outstanding amounts, net of discount, as current liabilities at December 30, 2012.~~

~~Senior Subordinated Secured Convertible Promissory Notes~~

~~During the 13 week period ended December 30, 2012 the Company issued an additional $4,210,000 of Senior Subordinated Secured Convertible Promissory Notes (the “2012 Notes~~”). The 2012 Notes are convertible at $0.12 per share, or the price of shares sold by the Company to one or more investors and raising gross proceeds to the Company of at least $1.0 million. Since the conversion price was not fixed, such instrument was considered to be a derivative. As such, the Company recorded approximately $237,000 as a derivative liability and related debt discount. The 2012 Notes are due March 31, 2013. As of December 30, 2012, the Company has $5,410,000 of 2012 Notes outstanding.

~~Subsequent to December 30, 2012, the Company authorized the issuance of Senior Subordinated Convertible Promissory Notes (the “2013 Notes~~”) that are a part of a series of notes, along with the 2012 Notes, in the aggregate amount of $10 million. As additional consideration for the purchase of the 2013 Notes, the Company shall issue shares of its common stock to each investor with a value equal to 25% of the principal amount of the 2013 Notes purchased by such investor. The 2012 Notes previously issued were cancelled and exchanged by each investor for 2013 Notes. The maturity date of the 2013 Notes is the earlier of 6 months after issuance, or the closing of a debt or equity financing resulting in gross proceeds to the Company in excess of $5 million (a “~~Qualified Financing~~”). Further, within fifteen (15) business days after the closing of a Qualified Financing, each investor may convert the outstanding principal and interest under their 2013 Note into the securities issued in the Qualified Financing, on the same terms and conditions as the other investors in the Qualified Financing. ~~As of February 6, 2013 the Company has issued $7.4 million of the $10 million aggregate amount of these series of Notes.~~

~~Senior Subordinated Secured Promissory Notes~~

~~In March 2011, the Company issued and sold to two accredited investors, Costa Brava Partnership III L.P. (“Costa Brava”) and The Griffin Fund LP (“Griffin”) 12% Senior Subordinated Secured Promissory Notes due March 2013 (the “Senior Subordinated Notes~~”) in the aggregate principal amount of $4.0 million. In July 2011, the Senior Subordinated Notes were amended to permit the holders to demand repayment any time on or after July 16, 2012, in partial consideration for permitting the issuance of additional Subordinated Secured Convertible Promissory Notes as discussed below. The owners of the Senior Subordinated Notes have not demanded payment through December 30, 2012.

~~-10-~~

~~Table of Contents~~

The Senior Subordinated Notes bear interest at a rate of 12% per annum paid by adding the amount of such interest to the outstanding principal amount of the Senior Subordinated Notes as “paid-in-kind” (“~~PIK”) interest. As a result of the addition of such interest, the outstanding principal amount of the Senior Subordinated Notes at December 30, 2012 was $4.9 million.~~

The Senior Subordinated Notes are secured by substantially all of the assets of the Company pursuant to Security Agreements dated March 16, 2011 and March 31, 2011 between the Company and Costa Brava as representative of the Senior Subordinated Note holders, but the liens securing the Senior Subordinated Notes are subordinate to the liens securing the indebtedness of the Company to PFG under the Senior Secured Revolving Credit Facility.

~~Subordinated Secured Convertible Promissory Notes~~

In December 2010, the Company entered into a Securities Purchase Agreement with Costa Brava and Griffin, pursuant to which the Company issued and sold to Costa Brava and Griffin 12% Subordinated Secured Convertible Notes due December 23, 2015 (the “~~Subordinated Notes~~”), in the aggregate principal amount of $7.8 million and, in March 2011, the Company sold additional Subordinated Notes to Costa Brava and Griffin for an aggregate purchase price of $1.2 million. In July 2011, the Company sold Subordinated Notes to five accredited investors, including Costa Brava and Griffin, in the aggregate principal amount of $5.0 million. In addition, holders of existing notes with a principal balance of $1.1 million converted their Bridge Notes into Subordinated Notes during the year ended September 30, 2011.

The Subordinated Notes bear interest at a rate of 12% per annum, due and payable quarterly. For the first two years of the term of the Subordinated Notes, the Company has the option to pay all or a portion of the interest due on each interest payment date in shares of Common stock, with the price per share calculated based on the weighted average price of the Common stock over the last 20 trading days ending on the second trading day prior to the interest payment date. While the Revolving Credit Facility is outstanding, interest on the Subordinated Notes that is not paid in shares of Common stock must be paid by adding the amount of such interest to the outstanding principal amount of the Subordinated Notes as PIK interest. During the 13 week period ended December 30, 2012, the Company paid approximately $483,000 of interest costs in the form of 4,357,000 shares of common stock. The principal and accrued, but unpaid interest under the Subordinated Notes is convertible at the option of the holder into shares of the Common stock at an initial conversion price of $0.07 per share. The conversion price is subject to a full price adjustment feature for certain price dilutive issuances of securities by the Company, and proportional adjustment for events such as stock splits, dividends, combinations, etc. Beginning after the first two years of the term of the Subordinated Notes, the Company may force the conversion of the Subordinated Notes into Common stock if certain customary equity conditions have been satisfied and the volume weighted average price of the Common stock is $0.25 or greater for 30 consecutive trading days. As of December 30, 2012, the Company has not met the equity conditions to force the conversion of the Subordinated Notes.

The Subordinated Notes are secured by substantially all of the assets of the Company pursuant to a Security Agreement dated December 23, 2010 and July 1, 2011, as applicable, between the Company and Costa Brava as representative of the holders of Subordinated Note, but the liens securing the Subordinated Notes are subordinate in right of payment to Loans issued pursuant to the Senior Secured Revolving Credit Facility and the Senior Subordinated Notes.

As a result of the issuances of Subordinated Notes discussed above, the conversion of existing notes to Subordinated Notes and the application of PIK interest, the aggregate principal balance of the Subordinated Notes at December 30, 2012, exclusive of the effect of debt discounts, was $16.1 million. During the 13 week period ended December 30, 2012, approximately $30,000 principal of Subordinated Notes was converted into approximately 438,000 shares of common stock. The balance of the Subordinated Notes, net of unamortized discounts comprised of derivative liability, at December 30, 2012 was $6.8 million. The debt discounts will be amortized over the term of the Subordinated Notes, unless such amortization is accelerated due to earlier conversion of the Subordinated Notes pursuant to their terms. The Company paid a total of $1.0 million in cash commissions to an investment banker for services related to issuance of the Subordinated Notes, $682,000 of which was recorded as a deferred financing cost and the balance recorded as an offset to equity.

-11-

Table of Contents

As of and prior to the quarter ended December 31, 2013, the Company was not in compliance with certain debt covenants of the Revolving Credit Facility. As such, the table below summarizes the various waiver and forbearance extensions and all warrants (the “Waiver Warrants”) issued to PFG. The exercise price of the Waiver Warrants is equal to the lower of the next equity financing effective price (the "NEFEP") or a stated price per share determined on the date of issuance of each forbearance extension. Prior to the consummation of the Series D Offering, the exercise price of the Waiver Warrants was not fixed, causing each Waiver Warrant to be accounted for as a derivative liability. However, upon consummation of the Series D Offering, the exercise price of each Waiver Warrant became fixed at $0.042 per share and the Company reclassified the fair value totaling $2,834,000 to paid in capital. With the ninth forbearance and in connection with the loan modification, PFG waived its rights with respect with debt covenant compliance through December 31, 2014.

Forbearance	Extension Through Date	Exercise Price per share	Exercisable Share
Waiver	September 30, 2012	$0.042		2,045,455
Forbearance Extension	October 31, 2012	$0.042		2,045,455
Second Forbearance Extension	December 15, 2012	$0.042		2,045,455
Third Forbearance Extension	January 31, 2013	$0.042		2,045,455
Fourth Forbearance Extension	February 28, 2013	$0.042		2,045,455
Fifth Forbearance Extension	March 31, 2013	$0.042		2,045,455
Sixth Forbearance Extension	April 30, 2013	$0.042		2,045,455
Seventh Forbearance Extension	May 31, 2013	$0.042		2,045,455
Eighth Forbearance Extension	June 30, 2013	$0.042		2,045,455
Ninth Forbearance Extension	October 28, 2013	$0.01		2,232,142
Total				20,641,237

As of December 31, 2013, PFG has not exercised any Waiver Warrants.

Derivative Liability

Certain instruments, including the embedded conversion feature in certain of the Compay's outstanding debt and warrants, contain provisions that adjust the respective conversion or exercise ~~price~~prices in the event of certain dilutive issuances of securities, or exercise/conversion prices that are not fixed. These provisions required ~~that~~ the Company ~~book~~to record a derivative liability upon ~~issuance and has~~issuance. The Company re-measured the fair value of the derivative liability to be ~~$15,625,000~~$0.1 million as of December 31, 2013 and $19.2 million as of September 30, ~~2012.~~2013 (see Note 11 below for a description of the Company's fair value measurements).

The Company estimated the fair value of the derivative liability using the Binomial Lattice pricing model with the following ~~outlines the~~ significant ~~assumptions the Company used~~inputs, as outlined below, to estimate the fair value ~~information presented, with~~of the derivative liability as of December 31, 2013 and September 30, 2013:

	December 31, 2013			September 30, 2013
Risk free interest rate		0.38	%		0.40	%
Expected volatility		133.0	%		94.8	%
Expected dividends	None			None

Note 6 — Convertible Preferred Stock

Series B Preferred

In the year ended October 3, 2010 (“Fiscal 2010”), the Company sold and issued an aggregate of 3,490 preferred stock units (the “Series B Preferred”) at a purchase price of $700 per preferred stock unit. Each share of Series B Preferred is convertible at any time at the holder’s option into 2,000 shares of Common Stock at a conversion price of $0.50. During Fiscal 2010, the year ended October 2, 2011 (“Fiscal 2011”), and Fiscal 2012, 2,564 shares of Series B Preferred were converted into approximately 5,127,000 shares of the Company’s Common Stock. During Fiscal 2013, approximately 60 shares of the Company’s Series B Preferred were converted into 120,000 shares of the Company’s Common Stock. As a result of such conversions, approximately 866 shares of Series B Preferred were outstanding at December 31, 2013, convertible into approximately 1,732,000 shares of the Company’s Common Stock.

-12-

Table of Contents

The Series B Preferred is non-voting, except to the extent required by law. With respect to distributions upon a deemed dissolution, liquidation or winding-up of the Company, the Series B Preferred ranks senior to the Common Stock and Series D Preferred. The liquidation preference per share of Series B Preferred equals its stated value, $1,000 per share. The Series B Preferred is not entitled to any preferential cash dividends; however, the Series B Preferred is entitled to receive, pari passu with the Company’s Common Stock, such dividends on the Common Stock as may be declared from time to time by the Company’s Board of Directors.

Series D Preferred

On October 30, 2013, we filed the Certificate of Designations with the Delaware Secretary of State to designate 4,000 shares of the Company's preferred stock as Series D Preferred. Each share of Series D Preferred has a Stated Value of $10,000 and votes alongside our Common Stock on an as-converted basis. The Series D Preferred ranks junior to our Series B Preferred, but is senior to all future classes of our preferred stock. The Series D Preferred is not redeemable at the election of the holder, but the Company may redeem the Series D Preferred, in whole or in part, in exchange for a cash payment equal to the Stated Value of the shared of Series D Preferred redeemed. The holders of the Series D Preferred may elect, at any time, to convert the Series D Preferred into that number of shares of Common Stock equal to the Stated Value, divided by the current conversion price of $0.042 (the “Conversion Price”). The Series D Preferred also has a mandatory conversion provision that allows the Company to require conversion of all outstanding shares of Series D Preferred in the event the Company sells shares of common stock for at least $0.084 per share in a private financing or series of financings that result in aggregate gross proceeds of at least $10.0 million.

As of December 31, 2013, there were 2,757 shares of Series D Preferred issued and outstanding.

The following table summarizes equity activity for the quarter ended December 31, 2013 related to the sale of, and exchange of debt for, Series D Preferred and as discussed above in Note 5. The amounts presented include the impact of unamortized debt discount, derivative liability ~~utilizing the Binomial Lattice pricing model at the date of~~and deferred issuance ~~and December 30, 2012:~~ costs.


~~Risk free interest rate~~		~~0.3565~~	%
~~Expected volatility~~		~~87.9~~	%
~~Expected dividends~~	~~None~~

	Preferred Stock (Series D only)
	Shares		Amount		Paid-in Capital

Balance, September 30, 2013		-		9		181,443,000

Cash Proceeds from sale of Series D Preferred Stock and warrants, net of issuance costs of $219,000		452		4		4,296,000
Convertible debt exchanged for Series D Preferred stock		2,305		23		24,705,000
Convertible debt exchanged for restricted stock		-		-		13,111,000
Stock based compensation		-		-		1,535,000
Warrant derivatives reclassified to equity		-		-		2,834,000
Other equity activity, net		-		-		2,764,000

Balance, December 31, 2013		2,757		36		230,688,000

Note 47 — Common Stock Warrants and Stock Based Compensation

Common Stock Warrants. As of December ~~30, 2012,~~31, 2013, warrants to purchase a total of ~~33,616,000~~292.7 million shares of the Company’s ~~common stock~~Common Stock were outstanding, with a weighted average exercise price of ~~$0.20~~$0.07 per share and exercise prices ranging from ~~$0.07~~$0.001 per share to ~~$13.00~~$0.55 per share.

As of September 30, 2013, warrants to purchase a total of 71,194,000 shares of the Company’s Common Stock ~~Options.~~ ~~At December 30, 2012, the Company had 51.1 million options~~were outstanding, with a weighted average exercise price of ~~$0.25,~~$0.10 per share and ~~37.2 million~~exercise prices ranging from $0.001 per share to $0.55 per share.

Stock Incentive Plans. The Company’s stockholders approved the Company’s 2006 Omnibus Incentive Plan (the “2006 Plan”), which is designed to serve as a comprehensive equity incentive program to attract and retain the services of individuals essential to the Company’s long-term growth and financial success. The 2006 Plan permits the granting of stock options (including both incentive and non-qualified stock options), stock-only stock appreciation rights, non-vested stock and non-vested stock units, performance awards of cash, stock or property, dividend equivalents and other stock grants. Upon approval of the 2006 Plan, the Company’s 2003 Stock Incentive Plan (the “2003 Plan”), 2001 Non-Qualified Stock Option Plan (the “2001 Non-Qualified Plan”), 2001 Stock Option Plan (the “2001 Plan”) and 2000 Non-Qualified Stock Option Plan (the “2000 Plan”) (collectively, the “Prior Plans”) were terminated, but existing options issued pursuant to the Prior Plans remain outstanding in accordance with the terms of their original grants.

-13-

Table of Contents

As of December 31, 2013 and September 30, 2013, there are no outstanding and/or exercisable options to purchase the Company’s Common Stock under the 2001 Plan or the 2001 Non-Qualified Option Plan.

Pursuant to an amendment of the 2006 Plan by stockholders in March 2009, the number of shares of Common Stock reserved for issuance under the 2006 Plan automatically increases at the beginning of each subsequent fiscal year by the lesser of 1,250,000 shares or 5% of the Company’s issued and outstanding Common Stock of the Company outstanding on the last day of the preceding fiscal year. As a result, the number of shares issuable under the 2006 Plan increased by 485,000 shares in Fiscal 2010, by 1,250,000 shares in Fiscal 2011, by 1,250,000 shares in Fiscal 2012. As of December 31, 2013, there were 440,500 outstanding and exercisable options to purchase the Company’s Common Stock under the 2006 Plan with ~~a weighted average~~exercise prices ranging from $0.16 to $13.00. As of September 30, 2013, there were options to purchase 621,000 shares of the Company’s Common Stock outstanding and exercisable under the 2006 Plan, with exercise prices ranging from $0.09 to $13.00 per share.

In December 2010, the Company’s Board adopted the Company’s 2010 Non-Qualified Stock Option Plan (the “2010 Plan”) under which the Company’s eligible officers, directors and employees, consultants and advisors who qualify as “accredited investors” within the meaning of Rule 501 under the Securities Act, may be granted non-qualified stock options. 18,500,000 shares of the Company’s Common Stock were reserved for issuance under the 2010 Plan, and options to purchase 18,500,000 shares of the Company’s Common Stock at an exercise price of ~~$0.30. The unvested options~~$0.09 per share were issued to certain of the Company’s officers and directors in December 2010 pursuant to the 2010 Plan. As of December 31, 2013, there are 9,000,000 outstanding and exercisable options to purchase the Company’s Common Stock under the 2010 Plan at an exercise price of $0.09 per share. As of September 30, 2013, there were options to purchase 15,500,000 shares of the Company’s Common Stock outstanding under the 2010 Plan, of which options to purchase 15,250,000 shares were exercisable, ~~had no~~at an exercise price of $0.09 per share. No further grants may presently be made under the 2010 Plan.

In March 2011, the Company’s stockholders approved the Company’s 2011 Omnibus Incentive Plan (the “2011 Plan”) and reserved for issuance 46,500,000 shares of Common Stock under the 2011 Plan. The number of shares reserved for issuance under the 2011 Plan was increased to 446,500,000 shares, effective January 16, 2014. The 2011 Plan is designed to promote the interests of the Company and its stockholders by serving as a comprehensive equity incentive program to attract and retain the services of individuals capable of assuring the future success of the Company and to afford such persons an opportunity to acquire a proprietary interest, or otherwise increase their proprietary interest, in the Company. The 2011 Plan permits grants of stock options (including both incentive and non-qualified stock options), stock-only appreciation rights, restricted stock, restricted stock units, dividend equivalents, performance awards of cash, stock or property, other stock grants and other stock-based awards. As of December 31, 2013, there were options to purchase 160,497,000 shares of the Company’s Common Stock outstanding under the 2011 Plan, at exercise prices ranging from $0.042 to $0.150 per share, none of which were exercisable at December 31, 2013 due to a condition in the option agreement prohibiting the exercise of any option before the filing of an amendment to the Company’s Certificate of Incorporation to increase the Company’s authorized capital stock, which amendment was filed with the Delaware Secretary of State on January 16, 2014. The aggregate ~~intrinsic value. During~~number of shares of Common Stock issuable under all stock-based awards that may be made under the ~~13-week period~~2011 Plan at December 31, 2013 is 485,248,000 shares.

Below is a summary of stock option transactions during the three months ended December ~~30, 2012, there were no options granted or exercised.~~31, 2013:

	Number of Shares			Weighted Average Exercise Price per Share		Weighted Average Remaining Contractual Life (yrs)		Aggregate Intrinsic Value
Outstanding at September 30, 2013		51,752,000		$	0.20		7.7	$	-
Granted		146,938,000			0.04		9.8		-
Exercised		-			-		-		-
Forfeited/Cancelled		(28,633,000	)		0.14		7.7		-

Outstanding at December 31, 2013		170,056,000			0.08		9.4		-

Vested and expected to vest, December 31, 2013		144,547,600			0.08		9.4		-

Exercisable, December 31, 2013		79,610,000			0.11		9.0		-

-14-

Table of Contents

For the three months ended December, 31, 2013, the Company utilized the Black-Scholes valuation model for estimating the fair value of share-based compensation with the following assumptions:

	Three months ended			Three months ended
	December 31, 2013			December 31, 2012

Expected life	5.4 years			6.7 years
Expected volatility		169	%		88.1% -99.3	%
Expected dividend	None			None
Risk-free rate		1.6	%		1.1-1.3	%

The Company issues new shares of Common Stock to satisfy option exercises. Based on historical experience of option cancellations, the Company has estimated an annualized forfeiture rate of 15% and 7% for employee options for the three months ended December 31, 2013 and 2012, respectively. Forfeiture rates are adjusted over the requisite service period when actual forfeitures differ, or are expected to differ, from the estimate.

During the three months ended December 31, 2013, a total of 146.9 million options to purchase shares of the Company’s Common Stock were granted under the 2011 Plan, with an exercise price of $0.042. One-third of the grant vests immediately and the remaining two thirds vest in equal monthly installments over two years and expire on October 21, 2023. The options were granted in exchange for the cancellation of options to purchase 27.1 million shares of Common Stock previously granted that were both vested and unvested, pursuant to the Option Exchange Program. The Company treated these exchanges as a modification to the existing options. The Company recorded the incremental cost of the modification measured by the excess of the fair value of the modified award over the fair value of the original award immediately before the modification as additional compensation cost recognized over the requisite service period. For the three months ended December 31, 2013, a $1.5 million stock option expense was recognized related to these transactions under the Option Exchange Program.

Employee Stock Benefit Plan. The Company has established an employee retirement plan ~~the ESBP.~~(the “ESBP”). This plan provides for annual contributions to the Company’s Employee Stock Bonus Trust (“SBT”) to be determined by the Board of Directors and which will not exceed 15% of total payroll. ~~Relating~~As of December 31, 2013, the Company has not made any contributions to the SBT for the year ended September 30, 2014. In Fiscal ~~2012~~2013, the Company made a contribution of ~~6.0~~9.1 million shares of ~~common stock~~Common Stock with an estimated market value of ~~$600,000~~$272,000 to the SBT.

Deferred Compensation Plan. In September 2002, the Company established a deferred compensation plan, the Non-Qualified Deferred Compensation Plan, for certain key employees with long-term service with the Company. Annual contributions of Common Stock of the Company were made to a Rabbi Trust under such plan to be held for the benefit of the deferred compensation plan participants. The Board of Directors did not authorize a contribution to the Non-Qualified Deferred Compensation Plan for Fiscal 2012. During Fiscal 2013 the Board of Directors authorized a contribution of 14,000 shares to the Non- Qualified Deferred Compensation Plan. Participants’ potential distributions from the Rabbi Trust represent unsecured claims against the Company. The Rabbi Trust was established by the Company and is subject to creditors’ claims. Shares in this plan may be distributed to each plan beneficiary when they retire from service with the Company. At December 31, 2013, and September 30, 2013 there were 44,000 shares of the Company’s Common Stock were in the Rabbi Trust.

Note 58 — ~~Net~~ Loss per Share

~~The~~ Since the Company had a net loss from continuing operations for ~~each of~~ the ~~13 weeks~~three months ended December ~~30,~~31, 2013 and 2012, ~~and January 1, 2012, and accordingly,~~ there was no difference between basic and diluted loss per share in each of these ~~periods.~~fiscal years.

-15-

Table of Contents

The following table sets forth the computation of basic and diluted loss per common share:

	Three Months Ended
	December 31, 2013			December 31, 2012
Basic and Diluted Net Loss Numerator:
Loss from continuing operations	$	(513,000	)	$	(1,330,000	)
Income (loss) from discontinued operations		-			(834,000	)

Net loss	$	(513,000	)	$	(2,164,000	)

Basic and Diluted Net Loss Denominator:
Weighted average number of common shares outstanding		224,816,000			141,394,000

Basic and diluted loss per common share:
Loss from continuing operations	$	-		$	(0.01	)
Net income from discontinued operations	$	-		$	(0.01	)
Net loss per common share	$	-		$	(0.02	)

   13 Weeks Ended

December 30,
2012

January 1,
2012

Net Loss Numerator:
Loss from continuing operations    $ (2,164,000)       $ (8,027,000)
Loss from operations of discontinued operations    -       (223,000)

Net loss    $ (2,164,000)       $ (8,250,000)

Net Loss Denominator:
Weighted average number of common shares outstanding, basic and diluted    141,394,000       113,716,000

Basic and diluted loss per share
Loss from continuing operations $ (0.02) (0.07)
Loss from discontinued operations - (0.00)
Net loss per share, basic and diluted $ (0.02) (0.07)
Basic and diluted loss per share (0.02) (0.07)

    Options, warrants and convertible instruments outstanding at December 31, 2013 and September 30, 2013 to purchase approximately 896,632,000 and 594,951,000 shares of the Company’s Common Stock, respectively, were not included in the above computation because they were anti-dilutive.

Note 9 — Discontinued Operations

On March 19, 2013, the Company announced that it had discontinued the Government Business, and instead focus on the Company’s cyber-security business. As a result of the Company’s decision, the Company’s Government Business is classified as a discontinued operation in the consolidated financial statements of the Company.

The following summarized financial information relates to discontinued operations, consisting of the Government Business:

	Three Months Ended
	December 31, 2013		December 31, 2012
Total revenues	$	-	$	782,000

Cost and expenses
Cost of revenues		-		581,000
General and administrative expense		-		559,000
Research and development expense		-		476,000

Total costs and expenses		-		1,616,000
Net loss from discontinued operations (net of $0 tax)	$	-	$	(834,000	)

Included in the consolidated balance sheets are the following major classes of assets and liabilities associated with the Government Business as of December 31, 2013 and September 30, 2013:

	December 31, 2013		September 30, 2013
Accounts receivable, net	$	-	$	-
Prepaid expenses and other current assets		-		-
Current assets of discontinued operations		-		-
Unbilled revenues on uncompleted contracts		290,000		290,000
Property and equipment, net		-		7,000
Other assets		3,000		-
Non-current assets of discontinued operations		293,000		297,000
Accounts payable		87,000		141,000
Accrued expenses		438,000		438,000
Advance billings on uncompleted contracts		99,000		99,000
Current liabilities from discontinued operations	$	624,000	$	678,000

~~-12-~~-16-

Table of Contents

Options, warrants and convertible instruments outstanding totaling 315,446,000 and 317,778,000 at December 30, 2012 and January 1, 2012 respectively, are not included in the above computation because they were anti-dilutive.

~~Note 6 — Bivio Acquisition~~

The Bivio Transaction has been accounted for under the acquisition method of accounting. Accordingly, the Company has estimated the purchase price allocation based on the fair values of the assets acquired.

The preparation of the valuation required the use of significant assumptions and estimates. Critical estimates included, but were not limited to, future expected cash flows, including projected revenues and expenses, and applicable discount rates. These estimates were based on assumptions that the Company believes to be reasonable. However, actual results may significantly differ from these estimates.

~~The following table presents the calculation of the purchase price:~~

Cash $ 600,000
Fair value of warrants issued 85,000
Total purchase price $ 685,000

The following outlines the significant assumptions the Company used to estimate the fair value of the warrants using the Binomial Lattice pricing model as of the acquisition date on October 12, 2012:

~~Risk free interest rate~~		~~1.69~~	%
~~Expected volatility~~		~~92.20~~	%
~~Expected dividends~~	~~None~~

Under the acquisition method of accounting, the total estimated purchase price is allocated the tangible and intangible assets and assumed liabilities based on their estimated fair values at October 12, 2012. Based on the Company’s valuation of the fair value of tangible and intangible assets acquired and liabilities assumed, which are based on estimates and assumptions that are subject to change, the purchase price is allocated as follows:

Tangible Current Assets $ 142,000
Tangible Non-Current Assets 48,000
Liabilities assumed (798,000 )
Amortizable intangible assets 900,000
Goodwill 393,000
Total fair value of net assets acquired $ 685,000

~~The following table presents amortizable intangible assets acquired and their amortization periods:~~

Estimated
fair value Amortization period
Customer relationships $ 100,000 5.0 years
Trade name 300,000 10.0 years
Software 500,000 7.0 years
Total $ 900,000

~~-13-~~

~~Table of Contents~~

Note ~~7 — Concentration of Revenues and Sources of Supply~~

In the 13-week period ended December 30, 2012, direct contracts with the U.S. government accounted for 70% of the Company’s total revenues. The remaining 30% of the Company’s total revenues were derived from non-government sources.

As reclassified to reflect the Company’s results of continuing operations without the Thermal Imaging Business, which was sold to Vectronix, on January 31, 2012, in the 13-week period ended January 1, 2012, direct contracts with the U.S. government accounted for 99% of the Company’s total revenues. The remaining 1% of the Company’s total revenues during such periods were derived from non-government sources.

The Company primarily uses contract manufacturers to fabricate and assemble its stacked chip, microchip, information security and sensor products. At its current limited levels of sales, the Company typically uses a single contract manufacturer for a particular product line and, as a result, is vulnerable to disruptions in supply.

~~Note 8~~10 — Commitments and Contingencies

The Company leases certain facilities and equipment under cancelable and non-cancelable operating leases, with escalating rent provisions for facility leases. Future minimum payments under capital lease obligations and operating lease commitments for the next five years as of December 31, 2013 are as follows:

Fiscal Year	Capital Leases			Operating Leases
2014 (remaining nine months)	$	362,000		$	203,000
2015		128,000			245,000
2016		42,000			243,000
2017		25,000			175,000
2018		-			149,000
2019 and beyond		-			-
Less amounts representing interest		(56,000	)		-

Future minimum lease payments	$	501,000		$	1,015,000

Total rent expense for operating leases amounted to $67,000 and $8,000 for the three months ended December 31, 2013 and 2012, respectively. Rent expense is recognized on a straight-line basis over the lease period. Deferred rent amounts are immaterial.

Litigation

The Company has been, and may from time to time, become a party to various other legal proceedings arising in the ordinary course of its business. The Company does not presently know of any such other matters, the disposition of which would be likely to have a material effect on the Company’s consolidated financial position, results of operations or liquidity.

Disputes

On December 6, 2013, a certain holder of Senior Subordinated Convertible Promissory Notes (the “Notes”) who chose not to convert into the Series D Offering (the “Non-Converting Note Holder”), totaling approximately $1.0 million, notified the Company that they interpreted the Notes to require the Company to use the net proceeds from the Series D Offering, to repay certain outstanding debts. In August 2013, however, the Company and the Non-Converting Note Holder amended the terms of the Notes to extend the maturity date of the Notes to January 31, 2014 (the “Amendment”), regardless of the consummation of a Qualified Financing, as such term is defined in the Notes. The Non-Converting Note Holder has objected to the Company’s interpretation of the Amendment, and has taken the position that the Notes are currently due and payable from proceeds of the Qualified Financing, notwithstanding the Company’s position that Amendment extended the maturity date of the Notes to January 31, 2014. As of February 14, 2014, the Notes remained due and payable, and the Company is continues to negotiate with the Non-Converting Note Holder to extend the maturity date of the Notes. In the event we are unable to reach an accommodation or negotiated settlement with the Non-Converting Note Holders, and are otherwise unsuccessful in defending our position, the Notes may become immediately due and payable, in which case we may be considered in default on the Notes.

On November 15, 2013 we failed meet a contractual first year minimum payment obligation of $100,000 with a certain vendor resulting in a contractual breach, which requires that we pay all fees and guarantee payment of totaling $1.8 million (the “Guarantee Payment”) immediately. We have not cured the breach of contract, but we have successfully negotiated a payment plan (the “Payment Plan”) with this vendor which consists of four equal monthly payments of $25,000 plus interest beginning February 2014. Due to our limited working capital, if we are unable to meet the requirements of the Payment Plan, we will be required to pay the Guarantee Payment in full, which could have a materially adverse impact on our business, financial condition and results of operations.

-17-

Table of Contents

Note 911 — Fair Value Measurements

The Company measures the fair value of applicable financial and non-financial assets and liabilities based on the following levels of inputs.

Level 1 inputs:Level 1 inputs are quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date.

Level 2 inputs:Level 2 inputs are from other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly.

Level 3 inputs:Level 3 inputs are unobservable and should be used to measure fair value to the extent that observable inputs are not available.

The hierarchy noted above requires the Company to minimize the use of unobservable inputs and to use observable market data, if available, when determining fair value. There were no transfers between Level 1, Level 2 and/or Level 3 during the ~~13 weeks~~three months ended December ~~30, 2012.~~31, 2013. Financial liabilities carried at fair value as of December ~~30, 2012~~31, 2013 are classified below:

Level 1 Level 2 Level 3 Total
Derivative liabilities $ - - 15,625,000 15,625,000

Total $ - - 15,625,000 15,625,000

		Level 1				Level 2				Level 3				Total
Derivative liabilities		$	-			$	-			$	124,000			$	124,000

The table below sets forth a summary of changes in the fair value of our Level 3 financial instruments for the ~~13 weeks~~year ended December ~~30, 2012:~~31, 2013:

September 30, 2012

Recorded
New Derivative
Liabilities

Change in
estimated fair
value recognized
in results
of operations

December 30,
2012

Derivative liabilities $ 19,925,000 $ 646,000 $ (4,947,000) $ 15,625,000

		September 30, 2013				Recorded New Derivative Liabilities				Warrant Derivatives Reclassified to equity				Extinguished in Conversion of debt to Series D Preferred and RSUs		Change in estimated fair value recognized in results of operations				December 31, 2013
Derivative liabilities		$	19,245,000			$	33,000			$	(2,834,000)			(8,986,000)		$	(7,334,000)			$	124,000

Fair Value of Financial Instruments. The Company estimates the fair value of financial instruments that are not required to be carried in the condensed consolidated balance sheet at fair value on either a recurring or non-recurring basis as follows:

	December 31, 2013				September 30, 2013				Level in fair
	Carrying amount		Fair value		Carrying amount		Fair value		value hierarchy

Cash and cash equivalents	$	375,000	$	375,000	$	136,000	$	136,000		1
Accounts Receivable, net	$	-	$	-	$	119,000	$	119,000		2
Accounts Payable	$	823,000	$	823,000	$	1,024,000	$	1,024,000		2

The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and approximated fair value due to their short-term nature.

Note 12 — Noncontrolling Interest in Subsidiaries

At December 31, 2013, the Company owned 96% of Novalog’s common stock, 98% of MSI’s common stock, 81% of RedHawk’s common stock, and 95% of iNetWorks’ common stock.

For the three months ended December 31, 2013 and 2012, Novalog, MSI, RedHawk, and iNetWorks did not have any operating activities.

~~-14-~~-18-

Table of Contents

Note 1013 — ~~Sale~~Subsequent Events

Amendment to 2011 Omnibus Incentive Plan and Option Exchange Program. On January 16, 2014, the Company implemented an amendment to its 2011 Omnibus Incentive Plan (the “2011 Plan”) to the increase the number of ~~Thermal Imaging Business~~shares of Common Stock issuable under the 2011 Plan to 446,500,000 (the “Plan Amendment”).

Senior Subordinated Secured Convertible Promissory 2013 Notes. On February 6, 2014, the Company’s board of directors approved the issuance of senior subordinated secured convertible promissory notes in the aggregate principal amount of up to $3.5 million (the “2014 Senior Subordinated Notes”), of which, $1.5 million may be issued in exchange for the cancellation of certain outstanding senior notes. The 2014 Senior Suborinated Notes mature on July 31, 2014. As ~~a result~~ of the ~~Thermal Imaging Asset Sale,~~date hereof, the ~~Company’s Thermal Imaging Business is classified as a discontinued operation~~Company has issued 2014 Senior Subordinated Notes in the ~~consolidated financial statements~~aggregate principal amount of $525,000.

As additional consideration, each holder of 2014 Senior Subordinated Notes will receive one share of Common Stock and a two year warrant to purchase one share of Common Stock at $0.042 for every $0.168 invested. The 2014 Senior Subordinated Notes shall pay 12% simple interest on a payment-in-kind (“PIK”) basis. At the close of $4.0 million equity security issued by the Company, the 2014 Senior Subordinated Notes will convert into shares of Series D Preferred at the election of the ~~Company. The following summarized financial information relates~~holder thereof in the event 50% or more of the holders elect to convert.

Loan Modification. On February 7, 2014 the Company entered into a second loan modification (the "Second Modification”) with an effective date of October 28, 2013, (the “Second Modification Effective Date”) to the ~~Thermal Imaging Business:~~Loan Agreement with PFG for the Revolving Credit Facility. In accordance with the terms of the Second Modification, in the event the Company consummates a debt or equity financing on or after the Second Modification Effective Date, the Company must pay to PFG 10% of the gross proceeds received from such financing. PFG, however, waived the deposit requirement for the month of January 2014. In consideration for the Second Modification, the Company has agreed to pay PFG a back-end fee of 15% on any capital transaction consummated on or after February 1, 2014.

13 Weeks Ended

January 1,
2012

Total revenues    $ 1,983,000

Cost and expenses
Cost of revenues    1,810,000
General and administrative expense    42,000
Research and development expense    354,000

Total costs and expenses    (2,206,000)

Loss from operations    (223,000)

Net loss from discontinued operations    $ (223,000)

~~-15-~~-19-

Table of Contents

~~ITEM 2.~~

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

In this report, the terms “ISC8 Inc.,” “ISC8,” “Irvine Sensors,” “Irvine Sensors Corporation,” “Company,” “we,” “us” and “our” refer to ISC8 Inc. (“ISC8”) and its subsidiaries.

Introduction

The following information should be read in conjunction with our unaudited condensed consolidated financial statements and notes thereto in Part I, Item 1 of this Quarterly Report on Form 10-Q (“Quarterly Report”), and with Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in our Annual Report on Form 10-K for the year ended September 30, ~~2012.~~2013, field with the SEC on December 24, 2013.

Overview

We are engaged in the design, development, ~~manufacture~~ and sale of a family of security products, consisting of cyber security solutions for government and commercial applications, secure memory products, some of which utilize technologies that we have pioneered for 3-D stacking of semiconductors, Systems in a Package (or SIP), and anti-tamper systems. In our government systems portfolio, we utilize technologies such as high-speed processor assemblies and miniaturized vision systems and sensors. In addition, we offer custom stacked solutions for other customer specific systems in package applications. We also perform customer-funded contract research and development related to these products, mostly for U.S. government customers or other prime contractors. We generally use contract manufacturers to produce our products or their subassemblies. Our current operations are located in California, Texas, and Italy with other employees and consultants in various other locations globally. Our operation in Italy was acquired in connection with our acquisition of certain software assets of Bivio Software in October 2012, described below.

~~As of December 30, 2012, we had approximately $31.4 million of debt, exclusive of debt discounts, and approximately $3.6 million of accounts payable and accrued expenses.~~

~~Acquisition of Bivio Software~~

~~On October 12, 2012, pursuant to the terms of the Foreclosure Sale Agreement between the Company and GF Acquisition Co. 2012, LLC (“GFAC”) dated October 4, 2012 (the “Foreclosure Sale Agreement”), the Company acquired substantially all of the assets of the NetFalcon and Network Content Control System Business (the "Bivio Software") of Bivio Networks, Inc. and certain of its subsidiaries (collectively, “Bivio”), an international provider of cyber security solutions and products. The purchase price of those assets (the “Acquisition~~”) was $600,000 payable in cash to GFAC, and the issuance to GFAC of a warrant to purchase capital stock of the Company. In addition, the Company assumed certain liabilities, including accounts payable, contractual obligations, reclamation obligations and other liabilities related to Bivio Software.

~~-16-~~

~~Table of Contents~~

Critical Accounting Estimates

Our consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”). As such, management is required to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The significant accounting policies that are most critical to aid in fully understanding and evaluating reported financial results are the same as those disclosed in our Form 10-K for the fiscal year ended September 30, ~~2012~~2013 filed with the SEC on December ~~28, 2012.~~24, 2013.

-20-

Table of Contents

Results of Continuing Operations

Overview of Results of Continuing Operations for Three Months Ended December 31, 2013 and December 30, 2012

Condensed Consolidated Results of Continuing Operations

The continuing operating results of our business for the three months ended December 31, 2013 and 2012 are as follows:

	December 31,			December 31,			Change			% change
	2013			2012 (1)

Revenues	$	93,000		$	93,000		$	-			-%
Cost of revenues		48,000			48,000			-			-%
Gross profit		45,000			45,000			-			-%
Operating expenses
General and administrative expense		2,375,000			2,368,000			7,000			-%
Research and development expense		1,898,000			1,968,000			(70,000	)		-4%
Total operating expenses		4,273,000			4,336,000			(63,000	)		-1%
Operating loss		(4,228,000	)		(4,291,000	)		(63,000	)		-1%
Interest and other (income) expenses
Interest expense		3,928,000			1,987,000			1,941,000			98%
Gain from change in fair value of Derivative liability		(7,334,000	)		(4,947,000	)		2,387,000			48%
Gain on extinguishment of debt		(316,000	)		-			(316,000	)		100%
Other (income) expense, net		4,000			(1,000	)		5,000			500%
Total interest and other (income) expenses		(3,718,000	)		(2,961,000	)		(757,000	)		-26%
Loss from continuing operations		(510,000	)		(1,330,000	)		(820,000	)		-62%
Provision for income taxes		3,000			-			3,000			100%
Loss from continuing operations		(513,000	)		(1,330,000	)		(817,000	)		-61%
Loss from discontinued operations (net of $0 tax)		-			(834,000	)		834,000			100%

Net income (loss)	$	(513,000	)	$	(2,164,000	)	$	(1,651,000	)		-76%

Basic and diluted net loss per share:	December 31,		December 31,
Basic and diluted net loss per share:	2013		2012			change		% change

Loss from continuing operations	$	-	$	(0.01	)	$	0.01		100%
Loss from discontinued operations	$	-	$	(0.01	)	$	0.01		100%
Net loss per share	$	-	$	(0.02	)	$	0.02		100%

Weighted average number of common shares outstanding		224,816,000		141,394,000			83,422,000		59%

(1)

On June 28, 2013, we changed our fiscal year end-date from the last Sunday of September to September 30. Accordingly, Fiscal 2013 ended on September 30, 2013, rather than September 29, 2013. We did not change our prior period presentation to reflect the change in fiscal year, as the difference is immaterial. See Note 1 of the Notes to the Condensed Consolidated Financial Statements contained in this Quarterly Report on Form 10-Q.

-21-

Table of Contents

The following discussions relate to ~~the Company’s~~our results of continuing operations after reclassifying the operations of our ~~Thermal Imaging~~Government Business as a discontinued ~~operation due to its sale~~operations upon the discontinuance of the Government Business on ~~January 31, 2012.~~

~~Total Revenues.~~ Our total revenues are generally derived from sales of specialized chips, modules, stacked chip products and amounts realized or realizable from funded research and development contracts, largely from U.S. government agencies and other government contractors. Our total revenues decreased in the 13-week period ended December 30, 2012 as compared to the 13-week period ended January 1, 2012 and changed in composition as shown in the following table and discussed more fully below.March 19, 2013.

13-Week Comparisons
   Total Revenues
13 weeks ended January 1, 2012    $ 1,297,000
Dollar decrease in current comparable 13 weeks    (422,000 )

13 weeks ended December 30, 2012    $ 875,000
Percentage decrease in current 13 weeks    (33%)

~~The decrease in our total~~ Total Revenues. Total revenues infor both the ~~13-week period~~three months ended December ~~30, 2012 as compared to the 13-week period ended January 1,~~31, 2013 and 2012 was ~~primarily the result~~$93,000. The revenue was generated from software maintenance revenue of a $676,000 decrease in funded research and development revenue. This decrease in total revenues was partially offset by a $254,000 increase in product sales related to our 3-D stacking business as well as our cyber ~~business. We believe~~security products primarily resulting from the ~~decrease in revenues derived from funded research~~acquisition of Bivio Software. Effective March 19, 2013, we discontinued our Government Business and ~~development contracts in~~completed our goal of transforming the 13-week period ended December 30, 2012 as compared to the 13-week period ended January 1, 2012 was substantially related to our current inability to obtain contracts under the Small Business Innovation Research (“SBIR”) program. Our inability to receive grants under the SBA could materially adversely affect our business, results of operations and financial condition.Company into a pure cyber security company. We are ~~unable~~continuing to ~~ascertain what future effects~~focus on the ~~U.S. defense budget timing may have on our total revenues for the balance~~development of the ~~fiscal year ended September 30, 2013 (“~~Cyber ~~Fiscal 2013~~adAPT® ”)product suite and ~~beyond. We~~ are currently promoting sales of our other recently introduced products, ~~which if achieved we~~Cyber NetFalcon® and Cyber NetControlTM. We believe these products could ~~still~~ become a material contributor to our total ~~revenues in the final reporting period of Fiscal 2013. However we are not certain~~revenue; however, no assurances can be given that such outcome will materialize during ~~Fiscal 2013~~the year ended September 30, 2014, or at all.

~~-17-~~

~~Table of Contents~~

Cost of Revenues. Cost of ~~revenues~~revenue includes wages and related benefits of our personnel ~~as well as subcontractor, independent consultant and vendor expenses~~ directly incurred in ~~the manufacture~~support of products sold or in the performance of funded research and development contracts, plus related overhead expenses and, in the case of funded research and development contracts, such other indirect expenses as are permitted to be charged pursuant to the relevant contracts. The comparison ofour software maintenance revenue. Our cost of ~~revenues~~revenue was $48,000 for the ~~13-week period~~three months ended December ~~30, 2012~~31, 2013 and ~~January 1, 2012 is shown in the following table and discussed more fully below:~~December 31, 2012.

13-Week Comparisons
   Cost of Revenues
Percentage of
Total Revenues

13 weeks ended January 1, 2012    $ 961,000    74 %
Dollar decrease in current comparable 13 weeks    (332,000)

13 weeks ended December 30, 2012    $ 629,000    72 %
Percentage decrease in current 13 weeks    (35%)

The decrease in absolute dollar cost of revenues in the 13-week period ending December 30, 2012 compared to the 13-week period ended January 1, 2012 is largely the result of comparatively low contract material costs and other direct costs relative to funded research and development revenue. Additionally, we experienced an increase in product sales, which have lower costs of revenue as compared to our funded research and development revenue.

General and Administrative Expense. General and administrative expense largely consists of wages and related benefits for our executive, financial, administrative and marketing staff, as well as professional fees, primarily legal and accounting fees and costs, plus various fixed costs such as rent, utilities and telephone. ~~The comparison of~~For the three months ended December 31, 2013 general and administrative expense ~~for~~was comparable to the ~~13-week~~prior year period ~~ended December 30, 2012 and January 1, 2012 is shown in the following table and discussed more fully below:~~at approximately $2.4 million.

13-Week Comparisons

General and
Administrative
Expense

Percentage of
Total Revenue

13 weeks ended January 1, 2012    $ 2,551,000 197 %
Dollar increase in current comparable 13 weeks    376,000

13 weeks ended December 30, 2012    $ 2,927,000    335 %
Percentage increase in current 13 weeks    15%

The increase in absolute dollars of general and administrative expense in the 13-week period ended December 30, 2012 as compared to the 13-week period ended January 1, 2012 consisted of a combination of increased stock-based compensation expense, marketing and legal fees, severance expenses, as well as facilities expense related to cyber development in Texas. This was partially offset by a decrease in travel, bid and proposal fees, professional fees, and stockholder-related expenses.

Research and Development Expense. Research and development expense primarily consists of wages and related benefits for our research and development staff, independent contractor consulting fees and subcontractor and vendor expenses directly incurred in support of internally funded research and development projects, plus associated overhead expenses. ~~Research~~For the three months ended December 31, 2013, research and development expense was comparable to the prior year’s period at approximately $2.0 million.

Interest Expense. For the three months ended December 31, 2013 interest expense increased $1.9 million to $3.9 million, or 98%, from $2.0 million in the comparable period in 2012. The increase in interest expense for the ~~13-week period~~three months end December 31, 2013 was primarily due to warrants issued to extend the 2013 Notes to January 31, 2014 totaling $2.2 million.

Change in Fair Value of Derivative Liability. For the three months ended December ~~30, 2012~~31, 2013, our gain from the change in fair value of derivative liability increased $2.4 million to $7.3 million, or 48%, from $4.9 million in 2012. On October 31, 2013 we completed the Series D Offering, considered to be a qualified financing, which fixed the conversion price of certain convertible notes and warrants, and, in turn, eliminated the embedded derivative therein. As a result Series D Offering, we revalued our embedded derivatives contained in the 2013 Notes, converted Senior Subordinated Notes and warrants as of October 31, 2013. We recognized a $6.8 million gain associated with the change in fair value related to these derivatives due to our lower stock price. The resulting fair value of these derivatives as of October 31, 2013 was extinguished in one of two methods. For the portion of the derivative securities held by related parties, we recognized the balance as contributed capital. For the portion of the derivative securities held by parties not otherwise related to the Company, we recognized the balance as a gain on extinguishment of debt. However, the conversion price of the remaining Senior Subordinated Notes will be based on the price of the next qualified financing consummated by the Company. Therefore, we revalued the embedded derivative on the remaining Senior Subordinated Notes as of December 31, 2013. The difference in the fair value resulted in a $0.6 million gain due to the lower stock price. The remaining Senior Subordinated Notes continue to have derivative features that can result in additional changes in the fair value of our derivative liability that we may be required to record in future reporting periods, unless and until our convertible debt instruments mature, are repaid, or are converted into common or preferred stock. No assurances can be given that we will not enter into additional convertible notes and warrants that have embedded derivative feature in the future.

Extinguishments of Debt. For the three months ended December 31, 2013, our gain on extinguishment of debt was $0.3 million. All of the debt converted into shares of Series D Preferred held by investors not related to the Company were treated as an extinguishment of debt. As such, the aggregate principal balance, accrued interest, unamortized discount, deferred cost, and respective derivative liability were compared to the ~~13-week period ended January 1, 2012 is shown~~fair value of the shares of Series D Preferred received in ~~the following table~~exchange for such cancelled debt, and ~~discussed more fully below:~~resulted in a $0.3 million gain on extinguishment of debt.

~~-18-~~-22-

Table of Contents

13-Week Comparisons

Research and
Development
Expense

Percentage of
Total Revenue

13 weeks ended January 1, 2012    $ 1,831,000 141 %
Dollar increase in current comparable 13 weeks    613,000

13 weeks ended December 30, 2012    $ 2,444,000    279 %
Percentage increase in current 13 weeks    33 %

~~The changes in research and development expense in~~ Net Loss from Continuing Operations. Our net loss from continuing operations decreased $0.8 million to approximately $0.5 million for the ~~13-week~~three months ended December 31, 2013, compared to $1.3 million for the three month period ended December ~~30,~~31, 2012, ~~as compared~~largely due to ~~the 13-week period ended January 1, 2012, are largely related to the development expenses~~a gain from change in fair value of ~~our Texas-based cyber security office, which we opened~~derivative instruments and ~~commenced staffing~~gain in ~~April 2011. Many~~extinguishment of ~~those expenses relate to hiring~~debt offset by higher interest expense of highly-skilled development and support staff, software licensing expenses, consulting fees and various operating leases of facilities and equipment to support product development. We also signed a joint development agreement$1.9 million associated with Cavium, Inc. to provide design and engineering services. We expect to continue to allocate significant resources to the development of our cyber security products in future periods, which may result in further increases in research and development expense as compared to prior fiscal periods. However, no assurances can be given that we will capitalize on our research and development initiatives.debt conversions.

~~Interest Expense.~~ Loss per Share. ~~Our interest expense~~Basic and diluted loss per share from continuing operations decreased by $0.01 to $0.00 for the ~~13-week period~~three months ended December ~~30, 2012, compared~~31, 2013, from $0.01 for the same period in 2012. Basic and diluted loss per share from discontinued operations decreased by $0.01 to $0.00 for the ~~13-week~~three months ended December 31, 2013, from $0.01 for the same period in 2012. Basic and diluted loss per share decreased by $0.02 to $0.00 for the three months ended ~~January 1, 2012,~~December 31, 2013, from $0.02 for the same period in 2012.

Liquidity and Capital Resources

Our liquidity in terms of both cash and cash equivalents increased in the first three months ended December 31, 2013, largely as a result of the timing of payments on our current payables and cash generated from our equity and debt financing. We continued to have a working capital deficit for the current period because we continued to generate losses as shown in the following table and discussed more fully below:

13-Week Comparisons
   Interest Expense
13 weeks ended January 1, 2012    $ 1,669,000
Dollar increase in current comparable 13 weeks    318,000

13 weeks ended December 30, 2012    $ 1,987,000
Percentage increase in current 13 weeks    19 %

	Cash and Cash Equivalents		Working Capital (Deficit)
September 30, 2013	$	136,000	$	(29,713,000)
Net Dollar increase as of December 31, 2013		239,000		23,082,000

December 31, 2013	$	375,000	$	(6,631,000	)
Percentage increase as of December 31, 2013		176%		78%

The $0.2 million increase in ~~interest expense in~~cash during the 13 weeks ended December 30, 2012 as compared to January 1, 2012 was attributable primarily to interest and amortization of debt discounts and financing related costs as a result of our capital structure and continued fund raising efforts.

~~Change in Fair Value of Derivative Liability.~~ ~~We recorded a substantial decrease in the change in fair value of derivative liability for the 13 week~~three month period ended December ~~30, 2012, as compared to the 13-week period ended January 1, 2012. This is shown in the following table and discussed more fully below:~~

13-Week Comparisons

Change in Fair Value of
Derivative Liability

13 weeks ended January 1, 2012    $ (2,310,000 )
Dollar decrease in current comparable 13 weeks    (7,257,000)

13 weeks ended December 30, 2012    $ 4,947,000
Percentage decrease in current 13 weeks    (314 %)

The Company revalued its derivatives as of December 30, 2012 and recorded a decrease in their fair value of approximately $4.9 million for the 13-week period, mainly as a result of quarterly valuations based on a decrease of our stock price from last quarter. Given the price volatility of our common stock, we anticipate that there could be additional substantial change in fair value of derivative liability expense that we will be required to record in future reporting periods, unless and until the Subordinated Notes are converted into, and/or the warrants are exercised for the purchase of common stock pursuant to their respective terms. Although no assurances can be given, in the event of such conversion or exercise, the derivative liability associated with these instruments would be eliminated.

~~-19-~~

~~Table of Contents~~

~~Net Loss from Continuing Operations.~~ Our net loss from continuing operations decreased in the 13-week period ended December 30, 2012, compared to the 13-week period ended January 1, 2012, as shown in the following table and discussed more fully below:

~~13-Week Comparisons~~	~~Net Loss~~ ~~from Continuing~~ ~~Operations~~
~~13 weeks ended January 1, 2012~~	$	~~(8,027,000)~~
~~Dollar decrease in current comparable 13 weeks~~		~~(5,863,000)~~

~~13 weeks ended December 30, 2012~~	$	~~(2,164,000)~~
~~Percentage decrease for current 13 weeks~~		~~(73%~~	)

~~The decrease in net loss from continuing operations in the 13-week period ended December 30, 2012 compared to the 13-week period ended January 1, 2012~~31, 2013 was largely due to a change in fair value of derivative instruments, a non cash item, discussed above which mainly related to lower stock prices during the current period, offset in part by an increase total cost and expenses and interest expenses in the comparable periods.

~~Liquidity and Capital Resources~~

Our liquidity in terms of both cash and cash equivalents decreased in the first 13 weeks of Fiscal 2012, largely as a result of losses generated from continuing operations, partially offset by an increase in product sales. As a result, we continued to have a working capital deficit for the current period as shown in the following table and discussed more fully below:

Cash and
Cash Equivalents

Working Capital
(Deficit)

September 30, 2012    $ 1,738,000    $ (10,091,000 )
Dollar decrease as of December 30, 2012    (1,311,000)    (5,906,000)

December 30, 2012    $ 427,000    $ (15,997,000 )
Percentage decrease as of December 30, 2012    (75% ) (59%)

~~The $1.3 million use of cash during the 13-week period ended December 30, 2012 is~~ a result of the following components: (i) cash used in operating activities of ~~$4.9~~$2.6 million ~~cash used in investing activities of $0.6 million, and~~offset by cash provided byfrom financing activities of ~~$4.2 million. Cash~~$2.9 million, (ii) cash used in operating activities ~~was a result~~consisted of the ~~$2.2~~$0.5 million net loss from continuing operations, (iii) $3.4 million in non-cash interest expense, (iv) $1.5 million in stock based compensation expense and ~~$4.9~~(v) a net change in operating assets and liabilities of $0.3 million, offset by $7.3 million change in fair value of derivative liability, ~~partially offset by $1.7 million in non-cash interest expense,~~ and other less significant factors related to various timing and cash deployment effects. Cash ~~used in investing activities was a result of $0.6 million related to acquisition related costs, and property and equipment expenditures. Cash~~ provided by financing activities was a result of ~~$4.2~~$4.4 million in proceeds from the sale of shares of Series D Preferred and $0.2 million in proceeds from the issuance of the ~~2012 Notes. The proceeds~~Senior Subordinated Secured Convertible Promissory Notes, partially offset by $2.0 million of principle payments on the PFG revolving credit facility.

For the three months ended December 31, 2013, our loss from ~~financing were the primary source of improvement in our working capital~~continuing operations was $0.5 million, as compared to a $1.3 million for the ~~current period.~~

three months ended December 31, 2012. As of December 31, 2013 we had negative working capital and stockholders’ deficit of approximately $6.5 million and $6.4 million as compared to $29.7 million and 55.6 million, respectively, at September 30, ~~2012~~2013. The increases in working capital and stockholders’ deficit was the due to the extinguishment of debt which were converted to Series D Preferred and RSUs, and the elimination of the related derivative liability resulting from the debt conversion.

As of December 31, 2013 we have used ~~a significant portion~~substantially all of the cash obtained from ~~both from~~the sale of the Thermal Imaging ~~Sale,~~Division, the Revolving Credit Facility and ~~2012~~2013 Notes to fund our operations, and have been unable to maintain positive cash flow during the ~~13-week~~three month period due to insufficient revenues. While we generated income in the current three months and had significant net losses previous fiscal years, the income in the current quarter was the result of various non-cash transaction associated with the change in fair value of the derivative for $7.3 million, gain on extinguishment of debt for $0.3 million offset by stock options expense for $1.5 million and non-cash interest expense of $3.4 million. We had approximately $0.4 million of cash on hand as of December 31, 2013. Our operating expenses during the quarter ended December 31, 2013 was approximately $4.3 million. To continue to fund anticipated operating expenses and satisfy indebtedness, we ~~will have to seek~~are currently seeking additional financing, and no assurances can be given that such financing ~~would~~will be available on a timely basis, on terms that are acceptable, or at all. Failure to do so and meet the repayment or other obligations of our existing debt could result in default and acceleration of debt maturity, which could materially adversely affect our business, and financial condition, and threaten our viability as a going concern.

~~-20-~~-23-

Table of Contents

At December 30, 2012, our funded backlog was approximately $1.3 million. Although no assurances can be given, we anticipate that a substantial portion of our funded backlog at December 30, 2012 will result in revenue recognized in the next twelve months. In addition, our government research and development contracts and product purchase orders typically include unfunded backlog, which is funded when the previously funded amounts have been expended or product delivery schedules are released. As of December 30, 2012, our total backlog, including unfunded portions, was approximately $1.4 million.

Contracts with government agencies may be suspended or terminated by the government at any time, subject to certain conditions. Similar termination provisions are typically included in agreements with prime contractors. While we have only experienced a small number of contract terminations, none of which were recent, we cannot assure you that we will not experience suspensions or terminations in the future. Any such termination, if material, could cause a disruption of our revenue stream, materially adversely affect our liquidity and results of operations and result in employee layoffs.

Off-Balance Sheet Arrangements

Our conventional operating leases are either immaterial to our financial statements or do not contain the types of guarantees, retained interests or contingent obligations that would require their disclosures as an “off-balance sheet arrangement” pursuant to Regulation S-K Item 303(a)(4). As of December ~~30, 2012~~31, 2013 and ~~September 30,~~ 2012, we did not have any other relationships with unconsolidated entities or financial partners, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.

Contractual Obligations and Commitments

Debt. At December ~~30, 2012,~~31, 2013, we had approximately ~~$31.4~~$6.0 million of debt, exclusive of discounts, which consisted of (i) ~~a Senior Secured~~the Revolving Credit Facility, in the ~~original~~ principal amount of ~~$5.0~~$3.0 million; (ii) Senior Subordinated Secured Convertible Notes issued during Fiscal with an aggregate principal balance of approximately ~~$5.4 million.;~~$1.6 million; and (iii) ~~Senior Subordinated Notes with an aggregate principal balance of approximately $4.9 million, and (iv)~~ Subordinated Secured Convertible Notes with an aggregate principal balance of approximately ~~$16.1~~$1.4 million. ~~Each of these~~These instruments are ~~described~~ more fully described below.

~~Senior Secured~~ Revolving Credit Facility

~~In December 2011, we entered into~~ On November 1, 2013, the Company substantially modified its Loan Agreement with PFG to provide, among other things, for a ~~Loan and Security Agreement (the “Loan Agreement”) with Partners for Growth, L.P. (“PFG”) pursuant to which we obtained~~one-year extension of the ~~two-year, $5.0 million line of credit (the “Revolving Credit Facility”). Upon execution of~~maturity date under the Loan Agreement ~~we borrowed~~to December 31, 2014 (the “PFG Loan Modification”). In return, the ~~entire $5.0~~Company made a $2.0 million ~~available thereunder~~repayment on the loan, deposited $500,000 with PFG as collateral for the loan, and, ~~used approximately $1.9~~in the event the Company consummates a debt or equity financing, the Company agreed to pay to PFG 25% of the proceeds from such financing. PFG and the Company also modified the Guaranty Agreement executed in connection with the Loan Agreement in order to: (i) release Costa Brava from its guarantee of the Company's debt to PFG, (ii) reduce the maximum guarantee amount to $1.0 million, and (iii) affirm the obligations of ~~that Revolving Credit Facility to repay~~Griffin under the ~~Secured Promissory Note. We used the remaining proceeds~~Guaranty Agreement.

As of December 31, 2013, the Revolving Credit Facility ~~less expenses thereof, for general working capital purposes.~~had a balance of approximately $3.0 million.

~~The maturity date for the Revolving Credit Facility is December 14, 2013 (the “Maturity Date~~”). Interest on the Revolving Credit Facility accrues at the rate of 12% per annum. Interest on the Revolving Credit Facility is payable monthly on the third business day of each month for interest accrued during the prior month, and the remaining balance is payable on the Maturity Date. Each of Costa Brava and Griffin, individually and collectively, jointly and severally, have unconditionally guaranteed repayment to PFG of $2.0 million of our monetary obligations under the Loan Agreement.

To secure the payment of all of our obligations under the Revolving Credit Facility when due, we granted to PFG a first position, continuing security interest in substantially all of our assets, including substantially all of our intellectual property, subject to the commitment by PFG to release any security interests in the assets of the Thermal Imaging Business that we sold. That sale was consummated on January 31, 2012, and PFG subsequently released the related security interests. In addition, Costa Brava, Griffin and certain other of our existing creditors have agreed that, while any obligations remain outstanding by us to PFG, their respective security interests in and liens on our assets shall be subordinated and junior to those of PFG.

~~-21-~~

~~Table of Contents~~

~~Senior Subordinated Convertible Notes~~

~~Effective as of September 28, 2012, the Company issued and sold to The Griffin Fund LP~~ Senior Subordinated Secured Convertible ~~Promissory~~ Notes ~~due November 30, 2012 in the aggregate principal amount of $1.2 million (the “2012 Notes~~”). The 2012 Notes are convertible at $0.12 per share, or the price of shares sold by the Company to one or more investors and raising gross proceeds to the Company of at least $1.0 million. During the 13 week period ended December 30, 2012 the Company issued $4,210,000 of 2012 Notes.

Payment in cash of an amount equal to all outstanding principal and accrued, but unpaid interest on the 2012 Notes was initially due November 30, 2012. The 2012 Notes were amended effective November 30, 2012 to change the maturity date of the 2012 Notes to March 31, 2013 (the “~~Maturity Date”).~~

~~Subsequent to December~~During the year ended September 30, ~~2012, the Company~~2013, we authorized the issuance of Senior Subordinated Secured Convertible ~~Promissory~~ Notes, ~~(the “2013 Notes”) that~~which notes are a part of a series of notes, ~~along with the 2012 Notes,~~ in the aggregate amount of $10 million. As additional consideration for the purchase of the 2013 Notes, the Company shall issue shares of its common stock to each investor with a value equal to 25% of the principal amount of the 2013 Notes purchased by such investor. The 2012 Notes previously issued were cancelled and exchanged by each investor for 2013 Notes. The maturity date of the 2013 Notes is the earlier of 6 months after issuance, or the closing of a debt or equity financing resulting in gross proceeds to the Company in excess of $5$10.0 million ~~(a “Qualified Financing~~”). Further, within fifteen (15) business days after the closing of a Qualified Financing, each investor may convert the outstanding principal and interest under their 2013 Note into the securities issued in the Qualified Financing, on the same terms and conditions as the other investors in the Qualified Financing. ~~As of February 6, 2013 the Company has issued $7.4 million of the $10 million aggregate amount of these series of Notes.~~

~~Senior Subordinated Notes~~

~~In March 2011, the Company issued and sold to two accredited investors, Costa Brava Partnership III L.P. (“Costa Brava”) and The Griffin Fund LP (“Griffin”) 12% Senior Subordinated Secured Promissory Notes due March 2013~~ (the “Senior Subordinated Notes”). As of December 31, 2013, Senior Subordinated Notes in the aggregate principal amount of ~~$4.0 million. In July 2011, the Senior Subordinated Notes~~$1.6 million were ~~amended to permit~~outstanding, and matured on January 31, 2014. We are currently negotiating with the holders of these notes to ~~demand repayment any time on or after July 16, 2012, in partial consideration for permitting~~extend the ~~issuance of additional~~maturity date.

Subordinated Secured Convertible ~~Promissory~~ Notes ~~as discussed below. Because of this demand, the Senior Subordinated Notes have been classified as current obligations in the Company’s Consolidated Balance Sheet as~~

As of December ~~30, 2012.~~

~~The Senior~~31, 2013, Subordinated Notes ~~bear interest at a rate of 12% per annum paid by adding the amount of such interest to the outstanding principal amount of the Senior Subordinated Notes as “paid-in-kind” (“PIK”) interest. As a result of the addition of such interest, the outstanding principal amount of the Senior Subordinated Notes at December 30, 2012 was $4.9 million.~~

~~Subordinated Secured Convertible Notes~~

In December 2010, the Company entered into a Securities Purchase Agreement with Costa Brava and Griffin, pursuant to which the Company issued and sold to Costa Brava and Griffin 12% Subordinated Secured Convertible Notes due December 23, 2015 (the “~~Subordinated Notes~~”) in the aggregate principal amount of ~~$7.8~~$1.4 million and sold in a subsequent closing in March 2011 additional Subordinated Notes to Costa Brava and Griffin for an aggregate purchase price of $1.2 million. In July 2011, the Company sold additional Subordinated Notes to five accredited investors, including Costa Brava and Griffin, in the aggregate principal amount of $5,000,000. In addition, holders of existing notes with a principal balance of $1.1 million converted their Bridge Notes into Subordinated Notes during Fiscal 2011.

~~-22-~~

~~Table of Contents~~

The Subordinated Notes bear interest at a rate of 12% per annum, due and payable quarterly. For the first two years of the term of the Subordinated Notes, the Company has the option to pay all or a portion of the interest due on each interest payment date in shares of common stock, with the price per share calculated based on the weighted average price of the Common Stock over the last 20 trading days ending on the second trading day prior to the interest payment date. While the Revolving Credit Facility iswere outstanding, interest on the Subordinated Notes that is not paid in shares of Common Stock must be paid by adding the amount of such interest to the outstanding principal amount of the Subordinated Notes as PIK interest. The principal and accrued but unpaid interest under the Subordinated Notes is convertible at the option of the holder into shares of the Common Stock at an initial conversion price of $0.07 per share. The conversion price is subject to a full price adjustment feature for certain price dilutive issuances of securities by the Company and proportional adjustment for events such as stock splits, dividends, combinations and the like. Beginning after the first two years of the term of the Subordinated Notes, the Company may force the Subordinated Notes to be converted to Common Stock if certain customary equity conditions have been satisfied and the volume weighted average price of the common stock is $0.25 or greater for 30 consecutive trading days. During the 13 week period ended December 30, 2012, the Company paid approximately $483,000 of interest costs in the form of 4,357,000 shares of common stock.

As a result of the issuances of Subordinated Notes discussed above, the conversion of existing notes to Subordinated Notes, the conversion of Subordinated Notes to common stock, and the application of PIK interest, the aggregate principal balance of the Subordinated Notes at December 30, 2012, exclusive of the effect of debt discounts, was $16.1 million. The balance of the Subordinated Notes, net of unamortized discounts comprised of derivative liability, at December 30, 2012 was $6.8 million. The debt discounts will be amortized over the term of the Subordinated Notes, unless such amortization is accelerated due to earlier conversion of the Subordinated Notes pursuant to their terms. The Company paid a total of $1,000,000 in cash commissions to an investment banker for services related to issuance of the Subordinated Notes, $682,000 of which ~~was recorded as a deferred financing cost~~$0.2 million will mature in December 2015, $0.2 will mature in January 2016, $0.1 million will mature in April 2016 and ~~the balance recorded as an offset to equity.~~

~~The Subordinated Notes are secured by substantially all of the assets of the Company pursuant to a Security Agreement dated December 23, 2010 and~~$0.9 million will mature in July 1, 2011, as applicable, between the Company and Costa Brava as representative of the holders of Subordinated Note, but the liens securing the Subordinated Notes are subordinate in right of payment to Loans issued pursuant to the Revolving Credit Facility.2016.

Capital Lease Obligations. The outstanding principal balance on our capital lease obligations of ~~$76,000~~$0.5 million at December ~~30, 2012~~31, 2013 relates primarily to computer equipment and software, and is included as part of current and non-current liabilities within our consolidated balance sheet.

Operating Lease Obligations. We have various operating leases covering equipment and facilities located at our offices in California, Texas, Italy, and Dubai.

-24-

Table of Contents

Deferred Compensation. We have a deferred compensation plan, the Executive Salary Continuation Plan (the “ESCP”), for select key employees. Benefits payable under the ESCP are established on the basis of years of service with ~~the Company,~~us, age at retirement and base salary, subject to a maximum benefits limitation of $137,000 per year for any individual. The ESCP is an unfunded plan. The recorded liability for future expense under the ESCP is determined based on expected lifetimes of participants using Social Security mortality tables and discount rates comparable to those of rates of return on high quality investments providing yields in amount and timing equivalent to expected benefit payments. At the end of each fiscal year, we determine the assumed discount rate to be used to discount the ESCP liability. We considered various sources in making this determination for ~~Fiscal 2012,~~three months ended December 31, 2013, including the Citigroup Pension Liability Index, which at ~~September 30, 2012~~December 31, 2013 was ~~3.94%~~4.95%. Based on this review, we used a ~~3.94%~~4.95% discount rate for determining the ESCP liability at ~~September 30, 2012.~~December 31, 2013. Presently, two of our retired executives are receiving benefits aggregating ~~$184,700~~$185,000 per annum under the ESCP. As of December ~~30, 2012, $1,159,000~~31, 2013, $1.2 million has been accrued in the accompanying consolidated balance sheet for the ESCP, of which amount $185,000 is a current liability included in accrued expenses in the attached Condensed Consolidated Balance Sheets as we expect to pay during Fiscal ~~2013.~~2014.

~~-23-~~

~~Table of Contents~~

Stock-Based Compensation

Aggregate stock-based compensation attributable to continuing operations for the ~~13-week~~three month periods ended December ~~30, 2012~~31, 2013 and ~~January 1,~~ 2012 was ~~$204,000~~$1.5 million and ~~$836,000, respectively, and was attributable to the following:~~$0.2 million, respectively.

13 Weeks Ended
December 30, 2012

13 Weeks Ended
January 1, 2012

Cost of revenues    $ 38,000       $ 63,000
General and administrative expense    166,000       773,000

   $ 204,000       $ 836,000

All transactions in which goods or services are the consideration received for equity instruments issued to non-employees are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of any such equity instrument is the earliest to occur of (i) the date on which the third-party performance is complete, (ii) the date on which it is probable that performance will occur, or (iii) if different, the date on which the compensation has been earned by the non-employee. In the year ended September 30, 2012, we issued to PFG warrants to purchase 15,000,000 shares of our common stock, valued at $250,000 pursuant to which the Company obtained the Revolving Credit Facility. We have recorded this expense as a debt discount, which is being amortized over the two-year term of the Revolving Credit Facility.

We calculate stock option-based compensation by estimating the fair value of each option granted using the Black-Scholes option valuation model and various ~~assumptions that are described in Note 1 of the Accompanying Notes to Condensed Consolidated Financial Statements included in this Quarterly Report.~~assumptions. Once the compensation cost of an option is determined, we recognize that cost on a straight-line basis over the requisite service period of the option, which is typically the vesting period for options granted by us. We calculate compensation expense of both vested and non-vested stock grants by determining the fair value of each such grant as of their respective dates of grant using our stock price at such dates with no discount. We recognize compensation expense on a straight-line basis over the requisite service period of a non-vested stock award.

For the ~~13-week period~~three months ended December ~~30, 2012,~~31, 2013, stock-based compensation included compensation costs attributable to such periods for those options that were not fully vested upon adoption of ASC 718, Compensation — Stock Compensation, adjusted for estimated forfeitures. We have estimated forfeitures to be ~~7%, which reduced stock-based compensation cost by $15,000 in~~15%. We granted options to purchase 146.9 million shares and we canceled 28.6 million shares during the ~~13-week~~three-month period ended December ~~30, 2012. The Company did not grant options~~31, 2013 pursuant to ~~purchase shares of common stock in~~ the ~~13-week period ended December 30, 2012. The Company granted of options to purchase 1,187,500 shares of common stock in the 13-week period ended January 1, 2012.~~Option Exchange Program.

~~At December 30, 2012,~~ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a "smaller reporting company" as defined by the ~~total compensation costs related~~rule and regulations of the Securities and Exchange Commission, we are not required to ~~non-vested option awards not yet recognized was $997,000. The weighted-average remaining vesting period of non-vested options at December 30, 2012 was 0.8 years.~~provide this information.

~~-24-~~-25-

Table of Contents

ITEM ~~3. QUANTITATIVE AND QUALITATIVE~~ ~~DISCLOSURES~~ ~~ABOUT MARKET RISK~~

~~Not required for smaller reporting companies.~~

~~ITEM~~ 4. CONTROLS AND PROCEDURES

~~(a)~~ Evaluation of Disclosure Controls and Procedures. Our management, with the participation of our Chief Executive Officer and our ~~Interim~~ Chief Financial Officer ~~has~~(our principal executive officer and principal financial officer, respectively), evaluated the effectiveness of our disclosure controls and procedures ~~(as~~as of Fiscal 2013. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the ~~Securities~~ Exchange Act, ~~of 1934, as amended (the “Exchange Act~~”)) as of the end of the period covered by this Quarterly Report. Based upon that evaluation, the Chief Executive Officer and the Interim Chief Financial Officer concluded that, as of the end of the period covered by this Quarterly Report, our disclosuremeans controls and other procedures ~~were effective in ensuring~~of a company that are designed to ensure that information required to be disclosed by usthe company in the reports that ~~we file~~it files or ~~submit~~submits under the ~~SEC~~Exchange Act is ~~(i)~~ recorded, processed, summarized and reported, within the time periods specified in the rules and forms of the ~~SEC~~Securities and ~~(ii)~~Exchange Commission ("SEC"). Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to ~~our~~the company’s management, including ~~our~~its principal executive and principal ~~accounting~~financial officers, ~~or persons performing similar functions,~~ as appropriate, to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of the quarter ended December 31, 2013, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

~~(b)~~ Changes toin Internal Control over Financial Reporting. We have undertaken, and will continue to undertake, an effort to comply with Section 404 of the Sarbanes-Oxley Act of 2002. This effort, under the direction of senior management, includes the documentation, testing and review of our internal controls. During the course of these activities, we identified potential improvements to our internal controls over financial reporting, ~~including~~ some ~~that~~of which we implemented induring the ~~first and second~~ quarter ~~of Fiscal 2012, largely~~ended December 31, 2013, including the modification or expansion of internal process documentation ~~and some that~~to support the changing direction of the Company. During the quarter ended December 31, 2013, we are currently evaluating for possible future implementation. During Fiscal 2012, we also commenced, but had not yet completed by December 30, 2012, the implementation of various software packages designedhired more experienced staff to ~~more fully integrate~~strengthen our ~~internal controls~~overall control environment, and to reduce the potential for ~~manual~~ errors ~~derived from multiple data entries.~~related to systems limitations. We expect to continue ~~documentation, testing~~to document, test and ~~review of~~improve our internal controls ~~on an on-going basis~~over the next year as our staff become more seasoned with the company, and ~~may identify other control deficiencies, possibly including material weaknesses, and other potential improvements~~believe our current staffing to ~~our internal controls in the future. We completed our ISO-9001 re-certification in June 2012 following consummation of the Thermal Imaging Asset Sale. We cannot guarantee~~be adequate. No assurances can be given that we will ~~remedy any~~not identify control deficiencies, including potential material weaknesses ~~that may be identified~~ in the future, or that we will ~~continue to~~ be able to ~~comply with Section 404 of the Sarbanes-Oxley Act.~~remedy any identified potential deficiencies or material weaknesses.

Other than as described above, there have not been any other changes that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

~~-25-~~-26-

Table of Contents

PART II

OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

None.

~~The information set forth under “Litigation” in Note 7 in the Accompanying Notes to Condensed Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report, is incorporated herein by reference.~~

ITEM 1A1A. RISK FACTORS

~~As of December 30, 2012 we~~ We have ~~used a significant portion of~~identified the ~~cash obtained from the Thermal Imaging Sale and the Revolving Credit Facility~~following risk factors in addition to fund our operations, and have been unable to maintain positive cash flow during the 13-week period due to insufficient revenues. To continue to fund anticipated operating expenses and satisfy indebtedness, we will have to seek additional financing, and we cannot provide assurance that such financing would be available on a timely basis, or on terms that are acceptable or at all. Failure to do so and meet the repayment or other obligations of our existing debt could result in default and acceleration of debt maturity, which could materially adversely affect our business, and financial condition, and threaten our viability as a going concern.

~~Other than as set forth above, there have been no other material changes in our assessment of~~ the risk factors ~~affecting our business since those presented~~previously disclosed in Part I, Item 1A, "Risk Factors" in our Annual Report on Form 10-K for the ~~fiscal~~ year ended September 30, ~~2012.~~2013:

Certain holders of the Company’s senior subordinated debt in the principal amount of approximately $1.0 million have notified the Company that such debt was due and payable as of November 1, 2013. Although the Company disputes this position, in the event the Company cannot successfully defend its position, the Company may be considered in default on such debt.

On December 6, 2013, a certain holder of Senior Subordinated Convertible Promissory Notes (the “Notes”) who chose not to convert into the Series D Offering (the “Non-Converting Note Holder”), totaling approximately $1.0 million, notified the Company that they interpreted the Notes to require the Company to use the net proceeds from the Series D Offering to repay certain outstanding debts. In August 2013, however, the Company and the Non-Converting Note Holder amended the terms of the Notes to extend the maturity date of the Notes to January 31, 2014 (the “Amendment”). The Non-Converting Note Holder has objected to the Company’s interpretation of the Amendment, and has taken the position that the Notes are currently due and payable from proceeds of the Series D Offering, notwithstanding the Company’s position that Amendment extended the maturity date of the Notes to January 31, 2014. Although the Company disputes the Non-Converting Note Holder's position, and believes that the Amendment extended the maturity date of the Notes to January 31, 2014, we may not prevail.

As of February 14, 2014, the Notes remained due and payable, and the Company is continuing negotiations with the Non-Converting Note Holder to extend the maturity date of the Notes. In the event we are unable to reach an accommodation or negotiated settlement with the Non-Converting Note Holders, and are otherwise unsuccessful in defending our position, the Notes may become immediately due and payable, in which case we may be considered in default on the Notes.

We are currently in breech of a contract with a vendor, which could, in turn, have a materially adverse effect on our business, financial condition and results of operation. Although we have negotiated a repayment plan, no assurances can be given that we can cure the breach or otherwise satisfy our remaining obligation.

On November 15, 2013, we failed meet a contractual first year minimum payment obligation of $100,000 with a certain vendor resulting in a contractual breach, which requires that we pay all fees and a guarantee payment of $1.8 million (the “Guarantee Payment”) immediately. We have not cured the breach of contract, but we have successfully negotiated a payment plan (the “Payment Plan”) with this vendor which consists of four equal monthly payments of $25,000, plus interest, beginning February 2014. Due to our anemic working capital, if we are unable to meet the Payment Plan, we will be required to pay the Guarantee Payment and our business, financial condition and results of operations could be materially and adversely affected.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

~~-26-~~-27-

Table of Contents

ITEM 6. EXHIBITS

~~3.1.1~~ 3.1		Certificate of Amendment to the Certificate of Incorporation of ISC8 Inc., dated January 16, 2014, attached as Exhibit 3.1 to the ~~Registrant~~ ~~(1)~~Current Report on Form 8-K, filed with the Securities and Exchange Commission on January 21, 2014, and incorporated by reference herein.
~~3.1.2~~	31.1	Certificate of Elimination of the Series B Convertible Cumulative Preferred Stock, Series C Convertible Cumulative Preferred Stock, Series D Convertible Preferred Stock and Series E Convertible Preferred Stock ~~(2)~~
~~3.1.3~~		~~Certificate of Designations of Rights, Preferences, Privileges and Limitations of Series A-1 10% Cumulative Convertible Preferred Stock~~ ~~(3)~~
~~3.1.4~~		~~Certificate of Amendment of Certificate of Incorporation to increase the authorized shares of the Corporation’s common stock and the authorized shares of the Corporation’s Preferred Stock~~ ~~(3)~~
~~3.1.5~~		~~Certificate of Amendment of Certificate of Incorporation to reclassify, change, and convert each ten (10) outstanding shares of the Corporation’s common stock into one (1) share of common stock~~ ~~(4)~~
~~3.1.6~~		~~Certificate of Designations of Rights, Preferences, Privileges and Limitations of Series A-2 10% Cumulative Convertible Preferred Stock~~ ~~(5)~~
~~3.1.7~~		~~Certificate of Designations of Rights, Preferences, Privileges and Limitations of Series B Convertible Preferred Stock~~ ~~(6)~~
~~3.1.8~~		~~Certificate of Designations of Rights, Preferences, Privileges and Limitations of Series C Convertible Preferred Stock~~ ~~(7)~~
~~3.1.9~~		~~Certificate of Amendment dated March 9, 2011 to Certificate of Incorporation to increase the authorized shares of the Company’s common stock~~ ~~(8)~~
~~3.1.10~~		Certificate of Amendment of Certificate of Incorporation to increase the authorized shares of the Corporation’s common stock from 500,000,000 to 800,000,000 and change of name of corporation to ISC8 Inc. from Irvine Sensors Corporation ~~(9)~~
~~3.2~~		~~By-laws, as amended and currently in effect~~ ~~(10)~~
~~31.1~~		Certification of the Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2		Certification of the ~~Interim~~ Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32		Certifications of the Chief Executive Officer and ~~Interim~~ Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).

101.INS *		XBRL Instance Document
101.SCH		~~XBRL Instance Document~~
101.SCH*		XBRL Taxonomy Extension Schema
101.CAL* 101.CAL		XBRL Taxonomy Extension Calculation Linkbase
101.DEF* 101.DEF		XBRL Taxonomy Extension Definition Linkbase
101.LAB* 101.LAB		XBRL Taxonomy Extension Label Linkbase
101.PRE* 101.PRE		XBRL Taxonomy Extension Presentation Linkbase

~~(1)~~

Incorporated by reference to Exhibit 3.1 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended September 28, 2003 as filed with the SEC on December 24, 2003 (File No. 001-08402).

~~(2)~~

~~Incorporated by reference to Exhibit 3.3 to the Registrant’s Current Report on Form 8-K as filed with the SEC on April 18, 2008.~~

~~(3)~~

~~Incorporated by reference to Exhibit 3.5 to the Registrant’s Current Report on Form 8-K as filed with the SEC on August 27, 2008.~~

~~(4)~~

~~Incorporated by reference to Exhibit 3.6 to the Registrant’s Current Report on Form 8-K as filed with the SEC on August 27, 2008.~~

~~(5)~~

~~Incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K as filed with the SEC on March 24, 2009.~~

~~(6)~~

~~Incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K as filed with the SEC on October 1, 2009.~~

~~(7)~~

~~Incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K as filed with the SEC on May 4, 2010.~~

~~(8)~~

~~Incorporated by reference to Exhibit No. 3.1 to the Registrant’s Current Report on Form 8-K as filed with the SEC on March 15, 2011.~~

~~(9)~~

~~Incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K as filed with the SEC on January 25, 2012.~~

~~(10)~~

Incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K as filed with the SEC on September 21, 2007, and by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K as filed with the SEC on December 29, 2010.

Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Exchange Act, and otherwise are not subject to liability under those sections.

~~-27-~~-28-

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	ISC8 INC.

	~~(Registrant)~~

~~Date: February 13, 2013~~	By:	/s/ ~~Edward J. Scollins~~Bill Joll Bill Joll
		~~Edward J. Scollins~~
		~~Interim~~ Chief ~~Financial~~Executive Officer
		and President (Principal ~~Financial and Chief Accounting~~Executive Officer) Dated: February 18, 2014

	13 Weeks Ended
	December 30, 2012			January 1, 2012
Total revenues	$	875,000		$	1,297,000

Cost and expenses
Cost of revenues		629,000			961,000
General and administrative expense		2,927,000			2,551,000
Research and development expense		2,444,000			1,831,000

Total costs and expenses		6,000,000			5,343,000

Loss from operations		(5,125,000	)		(4,046,000)
Interest expense		(1,987,000	)		(1,669,000)
Change in fair value of derivative liability		4,947,000			(2,310,000	)
Other income		1,000			1,000

Loss from continuing operations before provision for income taxes		(2,164,000)			(8,024,000)
Provision for income taxes		-			(3,000)
Loss from continuing operations		(2,164,000)			(8,027,000)

Loss from discontinued operations		-			(223,000)

Net loss	$	(2,164,000)		$	(8,250,000)

Basic and diluted loss per share
Loss from continuing operations	$	(0.02)		$	(0.07	)

Loss from discontinued operations		(0.00)			(0.00	)

Net loss per share, basic and diluted	$	(0.02)		$	(0.07	)

Weighted average number of common shares outstanding, basic and diluted		141,394,000			113,716,000

	13 Weeks Ended
	December 30, 2012			January 1, 2012
Cash flows from operating activities:
Net loss	$	(2,164,000	)	$	(8,250,000	)
Add: loss from discontinued operations		-			223,000
Loss from continuing operations		(2,164,000	)		(8,027,000	)

Adjustments to reconcile loss from continuing operations to net cash used in operating activities:
Depreciation and amortization		184,000			174,000
Non-cash interest expense		1,674,000			1,465,000
Change in fair value of derivative liability		(4,947,000	)		2,310,000
Non-cash stock-based compensation		235,000			836,000
Decrease in accounts receivable		38,000			158,000
(Increase) in unbilled revenues on uncompleted contracts		(93,000	)		(160,000	)
(Increase) in prepaid expenses and other assets		(70,000	)		(181,000	)
Increase (decrease) in accounts payable and accrued expenses		312,000			674,000
(Decrease) in Executive Salary Continuation Plan liability		(1,000	)		(15,000	)
Increase (decrease) in advance billings on uncompleted contracts		(19,000	)		12,000
(Decrease) in deferred revenue		(42,000	)		-
Total adjustments		(2,729,000	)		5,273,000
Net cash used in operating activities		(4,893,000	)		(2,754,000	)
Cash flows from investing activities:
Property and equipment expenditures		(53,000	)		(49,000	)
Net cash paid related to acquisition of Bivio		(569,000	)		-
Net cash used in investing activities		(622,000	)		(49,000	)
Cash flows from financing activities:
Proceeds from senior subordinated secured convertible promissory notes		4,210,000			-
Proceeds from revolving credit line		-			5,000,000
Debt issuance costs paid		-			(135,000	)
Principal payments of notes payable and settlement agreements		(4,000	)		(2,297,000	)
Principal payments of capital leases		(4,000	)		(2,000	)
Net cash provided by financing activities		4,202,000			2,566,000
Cash flows from discontinued operations:
Operating cash flows		-			(158,000	)
Investing cash flow		-			(263,000	)
Net cash used in discontinued operations		-			(421,000	)

Effect of foreign currency translation		2,000				-
Net decrease in cash and cash equivalents		(1,311,000	)		(658,000	)
Cash and cash equivalents at beginning of period		1,738,000			2,735,000
Cash and cash equivalents at end of period	$	427,000		$	2,077,000

Non-cash investing and financing activities:
Non-cash conversion of preferred stock to common stock	$	-		$	90,000
Conversion of Subordinated Secured Convertible Promissory Notes and accrued interest to common stock	$	30,000		$
Common stock issued to pay accrued interest and board fees	$	483,000		$	-
Issuance of warrants to acquire Bivio Software assets	$	85,000		$	-
Senior subordinated secured promissory notes issued to settle accrued interest	$	143,000		$	-
Issuance of warrants in connection with the Forbearance agreements	$	324,000		$	-
Supplemental cash flow information:
Cash paid for interest	$	152,000		$	134,000
Cash paid for income taxes	$	3,000		$	3,000

Cash	$	600,000
Fair value of warrants issued	85,000
Total purchase price	$	685,000

Tangible Current Assets	$	142,000
Tangible Non-Current Assets		48,000
Liabilities assumed		(798,000	)
Amortizable intangible assets		900,000
Goodwill		393,000
Total fair value of net assets acquired	$	685,000

	Estimated
	fair value		Amortization period
Customer relationships	$	100,000	5.0 years
Trade name		300,000	10.0 years
Software		500,000	7.0 years
Total	$	900,000

13-Week Comparisons	Total Revenues
13 weeks ended January 1, 2012	$	1,297,000
Dollar decrease in current comparable 13 weeks		(422,000	)

13 weeks ended December 30, 2012	$	875,000
Percentage decrease in current 13 weeks		(33%)

13-Week Comparisons	Cost of Revenues		Percentage of Total Revenues
13 weeks ended January 1, 2012	$	961,000		74	%
Dollar decrease in current comparable 13 weeks		(332,000)

13 weeks ended December 30, 2012	$	629,000		72	%
Percentage decrease in current 13 weeks		(35%)

13-Week Comparisons	General and Administrative Expense		Percentage of Total Revenue
13 weeks ended January 1, 2012	$	2,551,000		197	%
Dollar increase in current comparable 13 weeks		376,000

13 weeks ended December 30, 2012	$	2,927,000		335	%
Percentage increase in current 13 weeks		15%

13-Week Comparisons	Research and Development Expense			Percentage of Total Revenue
13 weeks ended January 1, 2012	$	1,831,000			141	%
Dollar increase in current comparable 13 weeks		613,000

13 weeks ended December 30, 2012	$	2,444,000			279	%
Percentage increase in current 13 weeks		33	%

13-Week Comparisons	Change in Fair Value of Derivative Liability
13 weeks ended January 1, 2012	$	(2,310,000	)
Dollar decrease in current comparable 13 weeks		(7,257,000)

13 weeks ended December 30, 2012	$	4,947,000
Percentage decrease in current 13 weeks		(314	%)

	13 Weeks Ended December 30, 2012		13 Weeks Ended January 1, 2012
Cost of revenues	$	38,000	$	63,000
General and administrative expense		166,000		773,000

	$	204,000	$	836,000